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DEVELOPMENT OF TOOLS FOR ATOM-LEVEL INTERPRETATION OF STABLE 
ISOTOPE-RESOLVED METABOLOMICS DATASETS 
 
Metabolomics is the global study of small molecules in living systems under a given 
state, merging as a new ‘omics’ study in systems biology. It has shown great promise in 
elucidating biological mechanism in various areas. Many diseases, especially cancers, are 
closely linked to reprogrammed metabolism. As the end point of biological processes, 
metabolic profiles are more representative of the biological phenotype compared to 
genomic or proteomic profiles. Therefore, characterizing metabolic phenotype of various 
diseases will help clarify the metabolic mechanisms and promote the development of novel 
and effective treatment strategies. 
Advances in analytical technologies such as nuclear magnetic resonance and mass 
spectroscopy greatly contribute to the detection and characterization of global metabolites 
in a biological system. Furthermore, application of these analytical tools to stable isotope 
resolved metabolomics experiments can generate large-scale high-quality metabolomics 
data containing isotopic flow through cellular metabolism. However, the lack of the 
corresponding computational analysis tools hinders the characterization of metabolic 
phenotypes and the downstream applications. 
Both detailed metabolic modeling and quantitative analysis are required for proper 
interpretation of these complex metabolomics data. For metabolic modeling, currently 
there is no comprehensive metabolic network at an atom-resolved level that can be used 
for deriving context-specific metabolic models for SIRM metabolomics datasets. For 
quantitative analysis, most available tools conduct metabolic flux analysis based on a well-
defined metabolic model, which is hard to achieve for complex biological system due to 
the limitations in our knowledge. 
Here, we developed a set of methods to address these problems. First, we developed 
a neighborhood-specific coloring method that can create identifier for each atom in a 
specific compound. With the atom identifiers, we successfully harmonized compounds and 
reactions across KEGG and MetaCyc databases at various levels. In addition, we evaluated 
the atom mappings of the harmonized metabolic reactions. These results will contribute to 
the construction of a comprehensive atom-resolved metabolic network. In addition, this 
method can be easily applied to any metabolic database that provides a molfile 
representation of compounds, which will greatly facilitate future expansion. In addition, 
we developed a moiety modeling framework to deconvolute metabolite isotopologue 
profiles using moiety models along with the analysis and selection of the best moiety 
model(s) based on the experimental data. To our knowledge, this is the first method that 
can analyze datasets involving multiple isotope tracers. Furthermore, instead of a single 
predefined metabolic model, this method allows the comparison of multiple metabolic 
models derived from a given metabolic profile, and we have demonstrated the robust 
performance of the moiety modeling framework in model selection with a 13C-labeled 
UDP-GlcNAc isotopologue dataset. We further explored the data quality requirements and 
     
 
the factors that affect model selection. Collectively, these methods and tools help interpret 
SIRM metabolomics datasets from metabolic modeling to quantitative analysis. 
 
 
KEYWORDS: Metabolomics, Atom-Resolved Metabolic Network, Maximum Common 
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CHAPTER 1. BACKGROUND 
1.1 Metabolomics 
Metabolomics can be generally defined as the comprehensive study of small-
molecule metabolites (<1500 Da) in a biological system (cell, tissue or organism) in a given 
state[1]. It is marked as the new ‘omics’, joining genomics, transcriptomics, and 
proteomics to achieve a better understanding of global systems biology[2]. Metabolites 
represent a wide range of molecules, such as lipids, amino acids, nucleic acids, vitamins 
and carbohydrates, playing various functions in biological systems, including energy 
production, macromolecules synthesis, and pathway signaling[3]. The quantitative 
collection of all metabolites present in a cell or organism involved in metabolic reactions 
is called the metabolome[4]. Compared to other ‘omics’ studies, metabolomics has a 
number of unique advantages[5].  First, metabolites are considered to be the molecular 
endpoint of many biological processes and an important molecular midpoint of most other 
biological processes. As the downstream of transcriptome and proteome, the metabolome 
can reflect the functional level of a cell more appropriately[6], suggesting metabolic 
profiles are more proximal to a biological phenotype than either genetic or proteomic 
profiles. Also, changes in the metabolome are supposed to be magnified relative to 
proteome or transcriptome. Additionally, the metabolic profiles are combinational results 
of gene expression and environmental stresses[7]. Therefore, metabolomics can provide 
great insights into the interaction of a biological system with its living environment.  
  It is becoming increasingly clear that metabolomics research can help open up 
many previously inaccessible biological fields, including health, disease, nutrition, 
environment and agriculture[8, 9]. One important area affected by metabolomics is 
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prokaryotic genome annotation. At least 30%-50% of genes in a bacterial genome are 
hardly or incorrectly annotated[10], and the function of 20% genes in the best understood 
bacteria genome is actually unknown[11]. Small molecule signatures would allow 
functional hypotheses and/or determination of those unknown genes. In addition, system 
wide analysis and understanding of metabolic processes have proven valuable in devising 
strategies of metabolic engineering for microorganisms[12]. More importantly, 
metabolomic studies can help with the identification of biomarkers for metabolic-related 
diseases[13] as well as the discovery and development of therapeutic agents[14, 15]. This 
will be discussed in more details in the next section. 
1.2 Metabolic Reprogramming 
Metabolic reprogramming is a critical feature in cancer and many other diseases. It 
has been recognized as one of the 10 hallmarks of cancer[16]. Back to 100 years ago, Dr. 
Warburg discovered that certain cancer cells predominantly produce energy through the 
glycolytic pathway rather than via the tricarboxylic acid (TCA) cycle even under normoxic 
conditions[17]. Despite the exact roles of metabolic reprogramming in cancers remaining 
unclear, advances in cancer metabolism research over the past decade have improved our 
understanding of how aerobic glycolysis and other metabolic alterations support the growth, 
proliferation and metastasis needs of cancer cells[18]. 
For example, glycolysis not only provides cancer cells with energy but also necessary 
precursors for biosynthesis (lipids, proteins, and carbohydrates). Several glycolytic 
metabolites, like glucose-6-phosphate, dihydroxyacetone phosphate, also take part in other 
metabolic pathways. Glucose-6-phosphate can be consumed by pentose phosphate 
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pathway to synthesize nucleotides. Dihydroxyacetone phosphate can be involved in lipid 
production[19].  
Apart from glycolysis, many cancer cells also rely on glutaminolysis for cellular 
bioenergetics. Glutaminolysis is composed of a set of reactions converting glutamine into 
glutamate, α-ketoglutarate, etc. These products are indispensable for TCA cycles in the 
cancer cells, and the intermediates of TCA cycles are the building blocks of lipids, amino 
acids and other important metabolites[20, 21].  
Increased lipid metabolism is another critical feature of cancer metabolism. Several 
enzymes, such as ATP citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), and fatty 
acid synthase (FASN), are involved in the multi-step lipid biosynthesis. Cancer cells need 
enhanced de novo fatty acid biosynthesis to meet their increased demands for lipids[22-24] 
FASN is upregulated in breast, prostate and other types of cancers[25-27]. In addition, 
cancer cells often have higher lipid accumulation as lipid droplets compared to normal 
cells[28]. 
In addition, upregulation of mitochondrial biogenesis, pentose phosphate pathway as 
well as other biosynthetic and bioenergetic pathways is also observed in certain cancer 
cells. The altered metabolism provides cancer cells with necessary energy as well as crucial 
materials to support rapid proliferation, survival, and invasion. Given the indispensable 
role of reprogrammed metabolism for cancers, it is promising to develop anti-cancer 
therapies targeting cancer bioenergetics. A lot of compounds have been studied and tested 
to selectively and effectively suppress metabolic enzymes that are essential to cancer cells.  
One of the most popular anti-cancer metabolism therapeutic strategies is to inhibit 
enzymes that are most or even exclusively expressed in cancer cell, which will effectively 
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kill tumors while causing little harm to normal cells. Inhibitors for Glutaminase 1 (GLS1), 
a glutaminase isoform that is highly upregulated in cancer cells, have proved to be effective 
in cancer treatment by blocking GLS1[29, 30]. Glycolysis inhibitors are also of great 
interest to many groups of researchers. For example, 2-deoxyglucose (2-DG) can block 
glycolysis by reversely inhibiting hexokinase, which is among the most advanced cancer 
metabolism inhibitors in clinical trials[31-33].  
Furthermore, metabolism therapies can be combined with other therapies to achieve 
better efficacy. Metabolic adaptation is often involved in the resistance to cancer 
treatment[34]. For instance, increased glycolysis has been associated with the resistance of 
breast cancer cells to HER-2-targeting trastuzumab. Synergistical combination of 
trastuzumab with glycolysis inhibitors have proven to be effective in trastuzumab-sensitive 
and trastuzumab-resistant breast cancers both in vitro and in vivo[35]. 
Recent remarkable advances in metabolic reprogramming have inspired exciting 
research in the development of anti-cancer metabolism therapies, which is expected to play 
important roles in the future clinical oncology. Large-scale characterization of metabolic 
phenotypes for various cancers will further help clarify the mechanisms of metabolic 
disease and promote the development of novel and effective treatment strategies. 
1.3 Metabolic Network and Metabolic Model 
Metabolomics data represents complex interaction among metabolites on a global 
scale rather than a collective of individual components[36]. Therefore, analyzing data from 
a network perspective is more likely to capture meaningful information that can be missed 
via differential analysis of individual metabolites. At an abstract but computationally useful 
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level, metabolic network can be represented as mathematical graphs, where each node is a 
specific metabolite and the edges describe the biotransformation pathways[37]. The 
representation of metabolic network as graph allows systematical investigation of the 
biological system via well-understood graph theoretical concepts and algorithms. 
Therefore, a high-quality reconstruction of metabolic network is of great interest to the 
community of scientific researchers working in the systems biology of metabolism. 
Huge efforts have been devoted to the reconstruction, such as Recon 1[38], the 
Edinburgh Human Metabolic Network (EHMN)[39], and Recon 2[40]. These are genome-
scale metabolic networks constructed by combining various sources of ‘omics’ and 
literature data. However, due to the limitations in our knowledge of the complexity of 
human genome, current reconstructions of the global metabolic network are not complete. 
For example, only about 1000 genes that are common to human Recon 1 and EHMN[41], 
promoting to the reconstruction of Recon 2 by harmonizing metabolic information in four 
different resources (EHMN[39], HepatoNet1[42], Ac-FAO module[43] and the human 
small intestinal enterocyte reconstruction[44]) to Recon 1[40]. In total, 7440 reactions and 
2626 unique metabolites are collected in the Recon 2. Even though EHMN, Recon, and 
Recon 2 are limited to human metabolism, compared to the KEGG (11427 reactions and 
18636 metabolites) and MetaCyc (17203 reactions and 20264 metabolites) repositories 
which cover known metabolism of many organisms, it can be seen that the reconstruction 
of comprehensive metabolic network still has a long way to go. However, efficient 
integration of metabolic data across different databases remains a big challenge. Non-
uniform compound identifiers and reaction names are two main blocks for the integration. 
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Clearly, many reactions in a genome-scale metabolic network are not active under a 
particular condition[45]. When it comes to analysis and interpretation of a specific 
metabolic profile, an essential step is to derive a predictive metabolic model for the 
corresponding context based on the global metabolic network. Such context-specific 
metabolic models are proven to exhibit better explanatory power and predictive 
performance than generic models[46, 47]. On the other hand, a comprehensive metabolic 
network is the premise for deriving context-specific metabolic models with high biological 
interpretability. 
1.4 Stable Isotope Resolved Metabolomics 
Since a metabolite can participate in many interweaved reactions, especially for some 
hot spots like glutamate, it is practically impossible to discern the contributions of each 
pathway segment only based on the metabolome[48]. To overcome this issue, isotopic 
tracers (2H, 13C, 14C, 15N and others) can applied in the metabolic studies, where an 
isotopically enriched precursor is applied to a biological system such that its metabolic 
transformations can be traced via the labeled atoms[49, 50]. 13C is the most frequently used 
stable isotope in cancer metabolism research. A lot of 13C-enriched precursors, like several 
isotopomers of D-glucose, are commercially available. Double element isotope-labeled 
metabolites like [U-13C,15N]-glutamine are also common. The wide variety of stable 
isotope-labeled sources greatly facilitate the experimental design for raveling the intricate 
metabolic segments. 
The typical stable isotope resolved metabolomics (SIRM) pipelines are shown in 
Figure 1.1[48]. Stable isotope tracers such as 13C-labeled glucose are first administrated to 
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the experimental targets via addition to the culture medium or through injection into the 
whole organism. The absorbed tracers will be used for synthesizing new metabolites. After 




Figure 1.1. Stable isotope-resolved metabolomics (SIRM) pipelines. 
 
Two chemical analytical features are derived from the incorporation of stable 
isotopes: isotopologues and isotopomers. Isotopologues are molecules that differ only in 
their isotopic composition[51]. Isotopomers are molecules having the same number of each 
isotope of each element but differing in their positions. Using alanine as an example (Figure 
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1.2), incorporation of 13C can generate 4 sets of distinct isotopologues and 8 distinct 
isotopomers. 
 
Figure 1.2. Isotopologues and isotopomers. 
 
Nuclear magnetic resonance (NMR) and mass spectroscopy (MS) are quintessential 
analytical tools for metabolite detection and characterization. While NMR is extremely 
powerful for elucidating organic structures at the atom position-specific level (i.e. 
isotopomer), it is disadvantaged by its poor sensitivity. Only metabolites present in 
relatively high concentrations can be reliably detected and quantified by NMR[1]. MS can 
measure isotopologue-specific data with higher sensitivity; however, an isotopologue 
represents a set of mass-equivalent isotopomers.  
When MS and NMR are applied in SIRM experiments, detailed sub-metabolite 
features representing isotopic flux through cellular metabolism can be detected on 
potentially thousands of metabolites in a biological system. However, it also brings another 

























1.5 Metabolic Flux Analysis 
Merely detecting all the metabolites in a biological system cannot directly reveal the 
most biologically and dynamically relevant aspect of metabolism, metabolic fluxes (i.e. the 
flow of materials through metabolism) [52]. For example, we can hardly know what lead 
to the accumulation or depletion of the target metabolites just based on their concentration. 
Quantitative and qualitative knowledge of metabolic fluxes over a metabolic model can 
help understand the contribution of each pathway segment, which provide insights into the 
regulation of metabolism[53, 54]. The metabolic flux analysis (MFA) can be defined as a 
collective set of techniques to derive the rates of metabolic reactions [55]. Initially, MFA 
depended solely on balancing fluxes around metabolites in the predefined metabolic model. 
As we discussed above, the stoichiometric constraints cannot provide enough information 
to calculate the fluxes of interest, especially for complex systems. Therefore, we 
incorporate stable isotopes into the biological system so that metabolites with distinct 
isotope-specific patterns can be produced. The isotope measurements provide plenty of 
additional independent constraints for MFA[56]. 
Several software packages have been developed to facilitate flux analysis. Earlier 
metabolic flux analysis focused on local fluxes[57-62]. To serve this purpose, only a small 
subset of metabolic features was used to calculate the predefined analytic formulas. This 
type of approaches is mathematically simple and rapid with significant limitations. Since 
these formulas are derived with strong intuition and tacit assumptions, only a dozen can be 
applied to interpret the central metabolism of microbes with single carbon tracer. Recently, 
more efforts have been devoted to achieving systematic metabolic fluxes analysis in an 
iterative fitting manner [55, 56, 63-66]. All the measured metabolic features are used to 
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estimate metabolic fluxes across the entire system. In this case, the fitting process of 
metabolic flux to detected metabolic data can be mathematically cumbersome. For 
complex system, it can take extensive computational time. Furthermore, this approach is 
not quite suitable for high-throughput analyses since it requires quantification of each 
sample individually. In addition, for complex metabolomics dataset, expert knowledge is 
required for quality control.  The final results heavily depend on the correctness of the 
metabolic model, the assumptions made, as well as the precision of detected data. 
Some machine learning algorithms also have been implemented for analyzing flux 
ratios based on 13C-labeled data[67]. In the SUMOFLUX machine learning model, the 
measured 13C isotope labeling patterns of the metabolites are the input features and the 
metabolic fluxes are the dependent variables to predict. Simulated data that fulfills the 
stoichiometric constraints of the metabolic network was generated to train the random 
forest model. Once the random forest predictor is constructed, it will be very efficient in 
estimating the metabolic fluxes for real data.  
The methods mentioned above do facilitate the interpretation of complex 
metabolomics datasets. However, they also show some obvious limitations. First, they all 
highly depend on a predefined metabolic model, which is feasible for well-understood 
metabolism. For complex biological systems especially for non-model organisms, the 
metabolic model is far from complete. In addition, these tools can only deal with 13C-data, 
which limits most of the current isotope tracer experiments to 13C tracer.  In Chapter 4, we 
developed the moiety modeling framework to address these problems. 
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1.6 Challenges in Interpreting SIRM Derived Metabolome 
To better decipher the complex metabolomics data, both detailed modeling and 
quantitative analysis are required. As we discussed above, a comprehensive metabolic 
network is the premise for deriving context-specific metabolic models. In a traditional 
metabolic network, each node is a specific metabolite, where information at atom level is 
not representative. Here, we can see that the gap of descriptions between metabolic network 
(metabolite level) and SIRM metabolic profiles (atom level). In this case, metabolic 
features containing isotopic details derived from SIRM experiments cannot be fully utilized 
in the construction of context-specific metabolic models. To bridge this gap, we need a 
metabolic network at atom level, where each node represents an atom from a specific 
metabolite rather than the whole metabolite. However, currently there are no relatively 
complete atom-resolved databases of metabolic networks available for human metabolism.  
In addition, we have discussed that it is difficult to construct a well-defined 
metabolic model for a complex system given our current level of knowledge of metabolism, 
particularly at the atom-resolved level. Since the current metabolic network is far from 
complete, multiple plausible metabolic models can be derived for a specific metabolic 
profile based on partial information. This causes another problem of model selection.  
However, this issue has not been fully studied yet.  Here, we can see that issues exist in 
metabolic modeling for SIRM datasets at various stages.  
The metabolic model is the cornerstone for downstream quantitative analysis. Our 
preliminary analysis indicated that a metabolomics dataset can have dramatically distinct 
metabolic fluxes interpretation under different metabolic models. Therefore, rigorous 
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method should be developed to facilitate initial model construction and ensure optimal 
model selection. 
1.7 Overview of Dissertation 
Even though a large volume of high-quality metabolomics data has been generated 
recently, there is still a lack of computational tools and methods for analyzing and 
interpreting those data, especially for metabolomics datasets derived from SIRM 
experiments. The overall goal for this dissertation is to develop computational tools and 
methods for analyzing and interpreting metabolomics data at the atom-resolved level. Here, 
we focused on two major parts, construction of a relatively complete atom-resolved 
metabolic network and development of moiety model framework for SIRM datasets.  
To construct an atom-resolved metabolic network, the very first step is to distinguish 
every node (i.e. an atom from a specific metabolite) in the network. In Chapter 2, we 
developed a neighborhood-specific coloring method for creating atom identifiers in a 
specific compound. In addition, compound identifiers derived from atom identifiers can be 
used for compound harmonization across various metabolic databases. Furthermore, we 
achieved hierarchical integration of metabolic reactions in KEGG and MetaCyc via an 
iterative combination of compound and reaction harmonization steps in Chapter 3. 
After constructing an atom-resolved network, the next step is to derive metabolic 
models based on the metabolic profile and metabolic network and achieve metabolic flux 
analysis. In Chapter 4, we described a moiety modeling framework for deconvoluting 
SIRM isotopologue datasets. Usually, multiple models can be derived from a specific 
metabolic profile. This method helps with the selection of optimal model for the 
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downstream analysis. In Chapter 5, we further analyzed how various factors (optimization 




CHAPTER 2. NEIGHBORHOOD-SPECIFIC COLORING METHOD FOR CREATING ATOM 
IDENTIFIER IN A COMPOUND 
2.1 Introduction 
Metabolic flux analysis is an essential approach to access metabolic phenotypes[53, 
65] that requires both reliable metabolic profiles as well as reliable metabolic models[68-
70]. Advances in analytical technologies like mass spectrometry (MS) and nuclear 
magnetic resonance (NMR) greatly contribute to the detection of thousands of metabolites 
from biofluids, cells, and tissues[71]. Application of those analytical techniques to stable 
isotope resolved metabolomics (SIRM) experiments facilitates production of high-quality 
metabolomics datasets capturing isotopic flux through cellular and systemic 
metabolism[48, 72]. Now, the challenge is to construct meaningful metabolic models from 
the corresponding metabolic profiles for downstream metabolic flux analysis. A metabolic 
network is usually represented by compounds connected via biotransformation routes[37]. 
Obviously, information at the atom level is not represented in such metabolic networks, 
making it impractical to derive appropriate metabolic models for SIRM datasets. Prior 
work demonstrated an atom-resolved metabolic network that included both central and 
intermediate metabolism in Escherichia coli that allowed atom-to-atom tracing[73, 74]. 
However, currently there are no relatively complete atom-resolved databases of metabolic 
networks available for human metabolism that can be used to trace individual atoms[72]. 
To construct an atom-resolved metabolic network, compounds and metabolic 
reactions with detailed documentation at the atom level are required. One approach is to 
reconstruct a hypothetical atom-resolved metabolic network from generalized reaction 
descriptions that are atom-specific[75]. However, it is unclear the level of validation and 
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curation that such an approach would require to construct a reasonably accurate atom-
resolved metabolic network for generating metabolic models usable in the analysis of 
SIRM datasets. An alternative is to use curated metabolic databases currently available, in 
particular the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the MetaCyc 
metabolic pathway database. The popular molfile description of a compound is a text-based 
chemical table file format developed by MDL Information Systems and contains 
information about atoms, bonds, connectivity, and coordinates[76], which is available in 
most databases including KEGG and MetaCyc. For atom-resolved metabolic reactions, the 
KEGG reaction pair (RPAIR) database stores patterns of transformations occurring 
between two reactants in a single reaction[77]. In addition, MetaCyc contains direct atom 
mappings for every metabolic reaction[78]. Previous work only made use of atom 
mappings in either the KEGG RPAIR database[79, 80] or MetaCyc[81] for atom tracing. 
However, both databases cover metabolism for many common organisms, clearly 
indicating that these two databases are not independent of each other. A necessary first step 
for constructing a more comprehensive network is to integrate compounds from different 
databases without redundancy[82]. 
In an atom-resolved metabolic network, each node should include information at 
both molecule-specific and atom-specific levels. To name each atom in a compound, two 
rules need to be obeyed: 1) different atoms must have different identifiers; 2) and 
symmetric atoms must share the same identifier. Previous work used the atom index in the 
molfile associated with a compound in finding atom-specific metabolic pathways without 
considering molecular symmetry[80, 81].  Likewise, molecular symmetry has been ignored 
in prior atom-resolved metabolic network reconstruction approaches[75]. One group tried 
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to assign a unique name for every atom in the compound based on the compound’s 
International Union of Pure and Applied Chemistry (IUPAC) International Chemical 
Identifier (InChI) representation[83], which does not apply to this scenario since symmetric 
atoms can share the same routes in the metabolic network. Also, any InChI-based approach 
cannot handle the compound entries with R-groups. To our knowledge, no appropriate 
method has been previously published that provides each atom in a compound with a useful 
identifier for the explicit purpose of constructing an atom-resolved metabolic network, 
either because the identifier was not unique or because it was not consistent for symmetric 
atoms. 
Here, we developed a novel neighborhood-specific graph coloring method that 
creates a unique identifier for each atom in a compound by expanding the type (color) of 
each atom based on its “neighborhood” of atoms (nodes) bonded (edges) to it. This 
approach is related to but distinct from atom typing performed in chemoinformatics, which 
determines an augmented atom type based on the local chemical environment, especially 
the directed bonded atoms[84].  Atom coloring creates an augmented atom type based on 
both directly and indirectly bonded atoms that are part of the graph neighborhood around 
a given atom. Moreover, the method is guaranteed to generate the same coloring identifier 
for symmetric atoms. Furthermore, compound coloring identifiers derived from the 
corresponding atom coloring identifiers can be used for compound harmonization across 
metabolic databases.  In this context, only molecular configuration (i.e. changes requiring 
the breaking of a bond) and not molecular conformation (i.e. changes not requiring the 
breaking of a bond like a bond rotation) are considered in the generation of these identifiers. 
To our knowledge, this is the first attempt to create unique atom and compound identifiers 
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that are consistent with respect to molecular symmetry and for the explicit purpose of 
harmonizing compounds across the KEGG and MetaCyc databases, ultimately to facilitate 
the construction of an integrated atom-resolved metabolic network. 
2.2 Materials and Methods 
2.2.1 Compound and metabolic reaction data 
All data were downloaded directly from the corresponding databases. The KEGG 
COMPOUND and KEGG REACTION data is from the version available from KEGG on 
May 2019 via its REST interface. MetaCyc compound and reaction data is in version 23.0, 
downloaded from BioCyc. 
2.2.2 Overview of major analysis steps 
A compound can be represented as a graph where each node is an atom in the 
compound and each edge between atoms is a chemical bond. Based on the molfile, we are 
able to create a graph representation for the corresponding compound. After we detect the 
aromatic substructures for a compound, we can change the bonds within the aromatic 
substructures to aromatic type (molfile[76] bond designation 4). After curation of aromatic 
substructures and double bond stereochemistry, we performed atom coloring and 
validation to guarantee that symmetric atoms share the same identifier and different atoms 
have different identifiers. Each set of atom identifers for a compound is used to derive the 
corresponding compound coloring identifier. Finally, we detect corresponded pairs of 
compounds across two databases using ordered compound identifiers for each compound 
in each database. The flowchart of the overall compound harmonization procedure is 





Figure 2.1. Overview of major compound harmonization steps. 
 
2.2.3 Molfile parser 
We used a modified ctfile Python 3 package[85] to parse a molfile into atom and 
bond blocks, and save them into the JavaScript Object Notation (JSON) format[86], 
facilitating access and modification. 
2.2.4 Aromatic substructure detection 
We used two methods in aromatic substructure detection. One is based on common 
subgraph isomorphism detection, and the other is an automatic aromatic atom detection 
method in Indigo packages[87]. In the KEGG database, aromatic atoms in a compound are 
specified in its KEGG Chemical Function (KCF) file[88]. Based on the aromatic atoms, 
we were able to extract the aromatic substructures present within a compound, and then 
saved every substructure into a separate molfile. If several aromatic rings are connected, 
we would fuse them together as one substructure. Then, we built a set of all aromatic 
substructures detected from the KEGG compounds without duplication. Furthermore, we 
manually inspected the set of aromatic substructures to ensure data quality. With this 
Parse molfile representation 
Detect aromatic substructure 
Color atoms and validate 
Detect corresponded compound pairs 
Generate ordered compound identifiers 
Identify double bond stereochemistry 
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curated set of reference aromatic substructures, we tested each compound in a database for 
the presence of any of these aromatic substructures using the BASS method[89]. We 
analyzed KEGG to validate the aromatic substructure detection method itself. Then, we 
analyzed MetaCyc and labeled the bonds of detected aromatic substructures as aromatic. 
Furthermore, valid aromatic substructures in MetaCyc compounds can be detected by 
Indigo and other IDs. Finally, we created 366 KEGG-derived and 21 MetaCyc-derived 
aromatic substructures in the reference aromatic substructure set. 
2.2.5 Identification of double bond stereochemistry 
The C=C double bond stereochemistry is not clearly specified in the molfile in both 
databases. To distinguish cis/trans stereoisomers, we adopted a method for automated 
identification of double bond stereochemistry[90]. This method requires fully 
hydrogenated compounds. Therefore, we first used Open Babel[91] to add hydrogen atoms 
for every compound, and then performed the calculation. 
2.2.6 Neighborhood-specific graph coloring method 
Our neighborhood-specific graph coloring method is based on a breadth first search 
algorithm[92]. This method names each atom based on its own and neighbors’ chemical 
information, which can include atom type, atom charge, atom stereochemistry, isotope, 
bond type, and bond stereochemistry. The method is flexible in adjusting the chemical 
information included in the atom coloring. A flowchart of the graph coloring method is 
shown in Figure 2.2. First, the method named each atom with its own chemical information, 
which will be saved as the 0_layer identifier and the start of the current atom identifier. 
Then, the method builds a dictionary that relates each atom with its 0_layer identifier and 
directly linked atoms. Directly bonded atoms of each atom are initialized as its neighbors. 
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The method continues to extend the name of each atom, adding information about its 
neighbors into the 0_layer dictionary to its current identifier, and updating neighbors with 
neighbors’ neighbors that have not been used in extending the name of that atom. The 
method first repeats this process 3 times for all the atoms to avoid early stopping that can 
lead to non-unique compound coloring identifiers. Then, the method checks if an atom has 
a unique identifier. Atom naming will continue for those atoms that still share the same 
identifiers with other atoms until all the atoms in the compound have been used in name 
extension. Finally, the current name for each atom will be its coloring identifier. Compound 
C00047 in the KEGG database (Figure 2.3) is used as an example to illustrate how the 
method works (Table 2.1). 
 
Figure 2.2. Flow chart of atom coloring. 
 
Name each atom with its own chemical information (0_layer & current identifier). 
Create a 0_layer dictionary of each atom with its own 
plus directly linked atoms’ 0_layer identifiers. 
Continue the above process if an atom does not 
have a unique current identifier.              
If an atom has a unique current identifier 
OR all the atoms in the compound has been 
used in name extension. STOP           
Initialize each atom’s neighbors with its directly linked atoms. 
Extend an atom’s current identifier with its neighbors’ information into 
the 0_layer dictionary, and update its neighbors with neighbors’ 




Figure 2.3. KEGG Compound C00047. 
 
Table 2.1. Generation of atom identifiers for compound C00047 via graph coloring method. 
Round Atom identifier Atom index 
1 
C 1, 2, 3, 5, 8, 9 
N 4, 10 
C 6, 7 
2 
C(C(C,1)(C,1)(N,1)) 1 
C(C(C,1)(C,1)) 2, 5, 8 
C(C(C,1)(O,1)(O,2)) 3 















Only chemical information of atom type and bond type is included in atom naming. The first three rounds of naming are 
shown above. 
 
2.2.7 Atom coloring validation and recolor 
The atom coloring validation and recoloring are also based on a breadth first search 
algorithm. The atom coloring validation flowchart is shown in Figure 2.4. For atoms with 
the same coloring identifier, we checked if neighbors of these atoms are also the same, 













method will correct atoms with the same identifier that don’t have the same neighbors. The 
recoloring process is similar to the graph coloring method. Instead of creating a 0_layer 
identifier dictionary, we will use a full identifier dictionary. In addition, we only color 
atoms to where they have different neighbors to distinguish between them.  
 
Figure 2.4. Flow chart of atom coloring. 
 
2.2.8 Creation of compound coloring identifiers based on atom coloring identifiers 
Once we create the identifiers for all the atoms in a compound, we can combine the 
number of atoms with the same identifier along with the atom coloring identifier. We sorted 
all the substrings, and then concatenated them together to form an ordered coloring 
identifier for the compound. The formulation is shown in Equation 1, which represents the 
order of string concatenation with nk being the number of atoms with coloring ak. The 
parenthesis and bracket characters are included in the resulting string. 
𝐶𝑜𝑚𝑝𝑜𝑢𝑛𝑑 𝑐𝑜𝑙𝑜𝑟 𝑖𝑑𝑒𝑛𝑡𝑖𝑓𝑖𝑒𝑟 =  (𝑛1)[𝑎1](𝑛2)[𝑎2](𝑛3)[𝑎3] … . (𝑛𝑘)[𝑎𝑘]             (1) 
Atoms in a compound share the same identifier. 
Create a full identifier dictionary of each atom 
with its own plus neighbors’ identifier.  
Check if the neighbors’ information in the dictionary is also the same for 
atoms with the same identifier, and update atoms’ neighbors with 
neighbors’ neighbors that have not been used in validation for that atom. 
If neighbors are the same, continue the above 
process until all the atoms in the compound 
have been used in validation for that atom. 
If neighbors are different, recolor these 
atoms till this layer. 
Initialize each atom’s neighbors with its directly linked atoms. 
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2.2.9 Prediction of possible compound correspondence via metabolic reactions 
We connected each compound with the metabolic reactions it is a part of. For 
matched compounds between KEGG and MetaCyc, we tested if the compound shares at 
least one metabolic reaction indicated by the EC number in both databases. 
2.3 Results 
2.3.1 Overview of KEGG and MetaCyc databases 
The numbers of compounds and atom-resolved reactions in KEGG and MetaCyc 
databases are summarized in Table 2.2. MetaCyc has 1.09 times as many compound entries 
as KEGG and 1.53 times as many atom-resolved reaction entries. 
Table 2.2. KEGG and MetaCyc databases 
Data types KEGG MetaCyc aMetaCyc/KEGG 
Compounds 18636 20264 1.09 
Reactions 11427 17203 1.51 
Atom-resolved reactions 10282 15909 1.53 
aRatio of MetaCyc entries to KEGG entries 
 
To initially evaluate the level of overlap between KEGG and MetaCyc databases, 
we used existing identifiers in each database to find the correspondences between KEGG 
and MetaCyc compounds. Not all compounds in either database have all the chemical 
identifiers listed in Table 2.3. Some compounds in MetaCyc have a direct identifier to the 
corresponding KEGG compound[81]. We can see that the number of matched compounds 
(correspondences) detected by different identifiers are not consistent, with the total less 
than 5700. We also generated InChI identifiers based on the molfile provided for each entry 
in each database using Open Babel[91], which utilizes the InChI software library provided 
by the InChI Trust[93].  We were able to generate 16530 InChI from KEGG and 15765 
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InChI from MetaCyc, providing 3103 correspondences.  When combined with ChEBI and 
KEGG Compound IDs, a total of 5929 consistent correspondences were detected.  Two 
issues may appear when applying these identifiers to compound integration across various 
databases. On the one hand, there is no easy way to check if some correspondences are 
missing. Besides, it is difficult to tell if the results generated by those identifiers are correct, 
since errors can exist in every database[83, 94]. Such errors are illustrated by the 964 out 
of 13216 KEGG compound entries with InChI that are inconsistent with the InChI 
generated from their associated molfile, representing 7.3% of the InChI-containing entries 
in KEGG. Likewise, 55 out of 15076 MetaCyc compound entries have InChI that are 
inconsistent with the InChI generated from their associated molfile, representing 0.4% of 
the InChI-containing entries in MetaCyc.  
Table 2.3. Correspondences between KEGG and MetaCyc compounds 
Identifiers KEGG MetaCyc Correspondences 
InChI 13216 (70.9%) 15076 (74.4%) 2336 
ChEBI 15353 (82.4%) 8404 (41.5%) 3106 
KEGG 18636 (100%) 5402 (26.7%) 5402 
Either-ID 18636 (100%) 15216 (75.1%) 5681 
InChI: IUPAC International Chemical Identifier. 
ChEBI: Chemical Entities of Biological Interest. 
 
Therefore, a reliable systematic naming method for chemical compounds that 
solves problems at the atom-level as well as the compound-level is required for 
constructing an atom-resolved metabolic network. Towards this end, we have developed a 
neighborhood-specific graph coloring method that derives unique identifiers for atoms as 
well as compounds. 
2.3.2 Aromatic substructure detection 
The neighborhood-specific graph coloring method is very sensitive to the specific 
structural representation. Moreover, aromatic substructures are not consistently 
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represented in both databases. Instead of being directly labeled as an aromatic bond type, 
single and double bonds are used alternatively to depict the aromatic substructure. CPD-
6962 in MetaCyc has a direct reference KEGG compound C15523 (Figure 2.5). We can 
see that the positions of double bonds and single bonds within the benzene ring vary 
between these two representations, which can lead to two different sets of atom identifiers. 
Therefore, we needed to ensure that compound representation is consistent across 
databases so that each compound will have a single set of atom identifiers. In this case, we 
first detect the aromatic substructures in all compounds from both databases, and change 
the single and double bonds within the aromatic substructure to aromatic bond. 
 
Figure 2.5. Correspondence between KEGG and MetaCyc compound entries with different 
molecular representations. 
 
Two independent aromatic detection methods were used in aromatic substructure 
detection: our Biochemically Aware Substructure Search (BASS) method[89] which uses 
neighborhood-specific graph coloring[95] to greatly improve subgraph isomorphism 
detection[96] and the aromatic detection facilities in the Indigo package[87]. First, we 
compared the aromatic substructures derived by these two methods. As shown in Table 2.4, 
Indigo appears more conservative than BASS in detecting aromatic substructures, 
detecting roughly 85% of what the BASS method does.  Figure 2.6 shows an example 
aromatic substructure that can be missed by Indigo. We assume that Indigo cannot detect 
aromatic substructures with a double bond connected to atoms outside of the ring. This is 
not surprising, since BASS leverages the curated set of aromatic substructures in KEGG 
MetaCyc: CPD-6962 KEGG: C15523 
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and has very high precision (99.9%) in the detection of aromatic substructures in KEGG 
compounds, while Indigo uses a set of simplified aromatic detection heuristics along with 
hard-coded algorithmic limitations of ring sizes being searched. However, we had concerns 
that some valid aromatic substructure representations in MetaCyc compounds may not 
exist in the reference aromatic substructure set derived from the KEGG database, which 
would be missed by the BASS method. This was confirmed by Indigo detecting 30 
additional MetaCyc compounds with aromatic substructures not detected by the BASS 
method. Therefore, we combined the KEGG aromatic substructures with additional Indigo-
detected substructures from MetaCyc. By using both methods, we were able to detect 
aromatic substructures in about half of the compounds in each database (Table 2.5). When 
an aromatic substructure was detected, all bonds for the aromatic substructure were 
changed to an aromatic bond type and the modified molfile was saved. All analyses were 
performed on a desktop computer with a i7-6850K CPU (6-core with HT), 64GB RAM, 
and 512GB solid state drive. On this hardware, the aromatic substructure detection took 
less than 5 minutes for KEGG and roughly 15 minutes for MetaCyc in terms of execution 
time. 
Table 2.4. Incomplete detection of aromatic substructures by BASS and Indigo 
Databases BASS Indigo 
KEGG 0 ~1500 





Figure 2.6. Example aromatic substructure that cannot be detected by Indigo. 
 
Table 2.5. Compounds with aromatic substructure 
Databases Count 
KEGG 9204 (49.4%) 
MetaCyc 8292 (40.9%) 
 
2.3.3 Generating identifiers for atoms using a graph coloring method 
Since symmetric atoms share the same neighbors, the graph coloring method is 
guaranteed to create the same identifier for them. Our concern is whether atoms with the 
same identifier are actually symmetric. In our graph coloring method, we only include 
0_layer identifiers in atom coloring to avoid long name strings. In some extreme cases, this 
shortcut can assign the same identifier to atoms that are asymmetric. An example is shown 
in Figure 2.7 A. We can see that this compound does not contain any symmetric atoms. 
Without considering the upper right ring, the bottom two rings are symmetric. Therefore, 
atoms 1 and 2 have the same 0_layer identifier, which is the same for atom pairs 4 & 5 and 
6 & 7. In addition, once atoms 1 and 2 reach atom 3, they will share the same route to the 
upper right substructure. Finally, atoms 1 and 2 will share the same coloring identifier 
(Figure 2.7 B) even though they are not symmetric. To deal with this problem, atom 
coloring validation and recoloring is performed. We can see that atoms 1 and 2 have distinct 








Figure 2.7. Example of compound with same atom identifier for asymmetric atoms using 
an overly simplistic coloring approach.  
A) KEGG compound C10782; B) The atom identifiers for atoms 1 and 2 before symmetry 
validation; C) The atom identifiers for atoms 1 and 2 after symmetry curation. 
 
We validate symmetry after a first round of coloring, recolor the compound if 
asymmetric atoms have the same identifier, and verify symmetry again. After this coloring-
validation-recoloring-validation process, our results indicated that the graph coloring 
method is able to generate the same identifier for symmetric atoms and asymmetric atoms 








































2.3.4 Detection of correspondences between KEGG and MetaCyc compounds via 
coloring identifiers. 
After creating a single set of atom identifiers for each compound, we were able to derive 
ordered compound coloring identifiers at different levels of chemical specificity, which 
can be used to harmonize compounds across databases. Since KEGG and MetaCyc can 
include different numbers of H (hydrogen atoms) in the molfile, we exclude H in coloring 
at this point. We first tried to include information of bond stereochemistry, atom charge, 
atom stereochemistry, and isotope stereochemistry in coloring to ensure each compound 
has a unique name. With the relatively specific coloring identifiers, 1763 correspondences 
between KEGG and MetaCyc compounds can be detected (see Table 2.6), which is not 
satisfactory compared to 5681 pairs discovered by other identifiers (e.g. KEGG, CHEBI, 
and InChI as shown in Table 2.3). This lack of correspondence is due to the inconsistencies 
in bond stereochemistry, atom charge, atom stereochemistry, and isotope stereochemistry 
information between these two databases. An example shown in Figure 2.8, where 
compound CPD-20570 in MetaCyc has a direct reference to KEGG compound C13014.  
 
Figure 2.8. Example of charge inconsistency of compound representations between 
databases.  
The middle harmonized compound representation enables loose coloring that facilitates 
compound harmonization. 
 
For the following analysis, we only included information of atom type and bond 








execution time on a desktop computer with a i7-6850K CPU (6-core with HT), 64GB RAM, 
and 512GB solid state drive to generate these coloring identifiers for all compound entries 
in the KEGG and MetaCyc databases. About 8865 correspondences between KEGG and 
MetaCyc are detected (see Table 2.6 and spreadsheets in supplementary material), and 
5451 of them can be confirmed by other identifiers. With both tight and loose compound 
coloring identifiers, about 95.95% compounds pairs detected by other chemical IDs can be 
discovered. We manually checked the compound pairs that were discordant with other 
chemical IDs and found that none of them are caused by an inconsistency between the 
coloring identifier and the compound representation.  The question then becomes how to 
validate the remaining 3414 possible pairs. Matched compounds are supposed to take part 
in the same metabolic reactions. The Enzyme Commission (EC) number is a numerical 
classification scheme for enzymes, playing a key role in classifying enzymatic reactions[97, 
98]. We expected matched compounds to take part in metabolic reactions with similar EC 
numbers.  
Table 2.6. Matched compounds detected by the compound coloring identifiers 
Identifiers Color matched pairs ID verified pairs 
Tight coloring identifier 1763 1448 
Loose coloring identifier 8865 5451 
 
Then, we analyzed the metabolic reactions in KEGG and MetaCyc databases (see 
Table 2.7). We can see that the documentation of EC number in KEGG is more complete 
compared to MetaCyc, but the number of metabolic reactions in MetaCyc is 50% larger 
than in KEGG. Around 80% of reactions in both databases can be related to at least a 3-
leveled EC number. 
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Table 2.7. Matched compounds detected by the compound coloring identifiers 
EC types KEGG (count / percentage) MetaCyc (count / percentage) 
No EC 1263 / 11.05% 3427 / 19.92% 
1-leveled EC 24 / 0.21% 11 / 0.06% 
2-leveled EC 126 / 1.10% 67 / 0.39% 
3-leveled EC 1081 / 9.46% 2958 / 17.19% 
4-leveled EC 8933/ 78.17% 10740 / 62.43% 
 
Next, we tested how well EC numbers work in the validation of correspondences 
between KEGG and MetaCyc compounds (See Table 2.8). We first identified color-
harmonized pairs that both take part in some reactions in their respective database. There 
are 4227 ID confirmed pairs and 2292 possible pairs involved in the metabolic reactions. 
We further investigated if those pairs participate into the same type of reaction indicated 
by EC number. If we used the first 3 levels of the sectioned EC number as the standard, 
3810 (90.13%) ID-confirmed pairs are verified by 3-leveled EC numbers. In addition, 3580 
of them can be further confirmed by 4-leveled EC numbers. Furthermore, 1848 and 1540 
possible pairs are confirmed by 3-leveled and 4-leveled EC numbers, respectively. These 
results suggest that EC numbers may be useful in validating possible pairs that have slight 
coloring deviations. All of the detected compound pairs are list in Supplementary 
Spreadsheet 2.1.  
Table 2.8. Correspondences between KEGG and MetaCyc compounds verified by 
reactions 
Conditions ID-confirmed pairs Possible pairs 
Pairs not in reaction 1224 1122 
Pairs in reactions 4227 2292 
Verified by 3-leveled EC 3810 1848 




2.3.5 Compound representation errors and issues detected in the KEGG and MetaCyc 
databases. 
When harmonizing compounds between KEGG and MetaCyc databases, we found 
that there are various compound representation issues and errors existing in both databases, 
which can be grouped into several categories like mismatch between compound image and 
molfile, incorrect cross-referencing, and different bonds attached to metal ions. Here, we 
give a brief description with some examples, and all the detected inconsistency is 
documented in Supplementary Spreadsheet 2.1.  
 
2.3.5.1 Incomplete KEGG aromatic atom types. 
KEGG atom types annotate every atom in every compound of the KEGG 
Compound database. The KEGG atom type of an atom maps that atom to a unique chemical 
substructure and these substructures often map to functional groups (e.g. the atom type 
“O1a” represents an oxygen of a hydroxyl group). However, the set of KEGG atom types 
are not complete, especially with regard to aromatic heterocycle atoms.  In particular, there 
are no oxygen and sulfur aromatic KEGG atom types defined, which prevents full 
automation of aromatic substructure determination based on KEGG atom type alone.  We 
used a simple heuristic method (i.e a simple deterministic decisioning approach) to 
consider oxygen and sulfur atoms as aromatic when they are part of a ring where all other 
carbon and nitrogen atoms are labeled as aromatic, based on KEGG atom types. But this 
aromatic substructure detection approach has limitations that requires some manual 
inspection, as highlighted in Figure 2.9. KEGG Compound entry C03861 contains a 1,4-
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dioxin flanked by aromatic rings. The 1,4-dioxin is not aromatic. In a counter-example, 
KEGG Compound entry C07729 contains an aromatic pyridine substructure flanked by 
benzyl rings.  The presence of both examples illustrates why aromatic substructure 
detection cannot be fully automated based on the current set of KEGG aromatic atom types. 
In addition, Figure 2.10 shows a KEGG compound with an S-containing aromatic ring. 
 As an aside, the quinoid fragment in KEGG Compound entry C03861 is likely 
mislabeled as aromatic, since quinoid fragments are standardly antiaromatic[99]. This 
quinoid fragment was likely mislabeled as aromatic due to the whole three-ring structure 
obeying Huckel’s rule. While we treated KEGG-identified aromatic substructures as 
completely correct, this example does indicate the presence of some error in KEGG’s 
aromatic substructure detection methods. Comparison of Indigo to KEGG may provide a 
means for detecting suspect KEGG aromatic substructures, but a manual inspection of all 
suspect substructures is not practical, especially from an automated analysis perspective. 
Moreover, aromatic mislabeling should not impact compound harmonization if applied 
consistently across databases.  
 
Figure 2.9. Compound with incomplete KEGG aromatic atom types.  
The middle ring of compound C03861 (left) is not aromatic while the middle ring of 
compound C07729 (right) is aromatic. 
 
 








2.3.5.2 Inconsistent compound representations. 
Using ID-based compound harmonization, we found that there are about 10 
MetaCyc compounds that contain valid aromatic substructures not detected by either the 
BASS or Indigo methods (Figure 2.11). To deal with this problem, we incorporated those 
valid aromatic substructures into the reference aromatic substructure set. 
 
Figure 2.11. Compound with different aromatic representations.  
These two corresponding compound entries across KEGG and MetaCyc have two different 
aromatic substructure representations. 
 
2.3.5.3 Incorrect cross-referencing 
There are some matched compounds detected by other identifiers that don’t have 
the same coloring identifier. Compound CPD-19437 in MetaCyc has a direct reference to 
KEGG compound C12187, but their coloring identifiers are different (see Figure 2.12). We 
can see that the compound representation in MetaCyc is not consistent with its counterpart 
in KEGG. In addition, CPD-19437 and C12187 have the same ChEBI reference compound 
32074, and the representation in ChEBI is the same with that of KEGG, suggesting the 













2.3.6 Estimating the error rate of the graph coloring method. 
2.3.6.1 Ambiguous coloring identifiers. 
During the compound harmonization process, tight atom and compound coloring 
was loosened (see Figure 2.8 for an example), keeping only atom type and bond type in the 
atom coloring for the final steps in compound harmonization. With the loose coloring, 
multiple compounds in one database can have the same coloring identifier. We first tested 
if a compound can have a unique coloring identifier when all information is included in the 
atom coloring with hydrogen (H) atoms excluded (Table 2.9). Here, we did not count 
compounds with a generic R group representing ambiguous functional groups and 
substructures; however, the results that include all compounds are described in Table 2.10. 
Several types of compounds cannot be distinguished by the tight coloring identifier except 
for those duplicates (Figure 2.13). When we only include atom type and bond type in the 
atom coloring, many more compounds share the same coloring identifier. After compound 
harmonization, we are able to detect compounds with the same coloring identifier from the 
source database. 
 
MetaCyc: CPD-19437 KEGG: C12187 ChEBI: 32074 
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Table 2.9. Compounds with the same coloring identifier, excluding R groups 
Databases Tight coloring identifier Loose coloring identifier 
KEGG 99 (0.5%) 968 (4.8%) 
MetaCyc 117 (0.6%) 1144 (5.6%) 
 
Table 2.10. Compounds with the same coloring identifiers, which includes R groups. 
Databases Tight coloring identifier Loose coloring identifier 
KEGG 209 (1.1%) 1132 (6.1%) 







Figure 2.13. Representative compounds that cannot be distinguished by coloring identifier. 
A) Compound and its radical form; B) Compound containing repeated substructure; C) 
Compound with R representing a generic group; D) Isomers containing C=N; E) 
Compounds after curation of aromatic substructures. 
 
 
KEGG: C02389 KEGG: C00530 KEGG: C00083       KEGG: C03188 
KEGG: C00484 KEGG: C01402 
KEGG: C04353 KEGG: C04350 
A B 





When the compound identifier is ambiguous, a compound in one database can be 
mapped to several different compounds in the other database during compound 
harmonization. For ID confirmed pairs, 28 MetaCyc compounds can be linked to more than 
one KEGG compound, which is caused by inconsistency of different ID references. Also, 
about 478 MetaCyc compounds have several KEGG correspondences among the 1848 
pairs verified by 3-leveled EC. This highlights the value in leveraging metabolic reactions 
and the corresponding atom mappings to disambiguate multiple possible mappings while 
constructing an integrated metabolic network. 
2.3.6.2 Pseudosymmetric atoms. 
Omitting information in the atom coloring can also lead to pseudosymmetric atoms. 
We tested if incorporation of atom charge, atom stereochemistry, or bond stereochemistry 
in the atom coloring will erase some symmetric atoms (Table 2.11). After addition of atom 
charge, 148 MetaCyc and 38 KEGG compounds lose symmetry. Most of them are caused 
by terminal atoms, like CPD-321 (Figure 2.14). Since either symmetric atom can be labeled 
with charge, asymmetry caused by atom charge can be ignored in constructing metabolic 
network. In addition, both databases contain compounds affected by bond and atom 
stereochemistry. We need to take bond and atom stereochemistry into consideration, since 
some enzymes are stereochemically specific. A heuristic method could be used to test if 
symmetric atoms are affected by bond and atom stereochemistry, and then atom coloring 
identifiers incorporated with bond and atom stereochemistry will be generated to overcome 
this issue. However, more complex molecular symmetries like that illustrated by KEGG 
C04167 will require the use of algorithms that can detect all possible molecular symmetries 
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(i.e. automorphisms induced by rotations and reflections of the 3 embedded graph) using 
a 3-dimensional representation of the compound[100]. 








KEGG 232 38 169 





Figure 2.14. Example compounds gaining asymmetry after the addition of tight atom 
coloring information.  
For CPD-321, the two oxygens bound to the nitrogen are asymmetric with tight atom 
coloring and symmetric with loose atom coloring. 
 
 
2.3.6.3 Changeable graph representation. 
There are two types of matched compounds that cannot be detected by coloring 
identifiers. One group of compounds can have either linear or circular representations (see 
Figure 2.15), and there are about 26 examples in this category. The other group is caused 
by resonance structures (see Figure 2.16), and we discovered about 46 similar cases. 
Artificial sets of atom mappings can be created to represent chemical transformations that 








Figure 2.15. Compound with linear and circular representations. 
 
 
Figure 2.16. Compound with different resonance structures. 
2.4 Discussion 
Here, we have developed a graph coloring method that creates unique identifiers for 
each atom in a compound with consideration for molecular symmetry. The atom-specific 
identifiers can capture additional cross-reaction atom mappings caused by symmetric 
atoms, which will contribute to the construction of a more complete atom-resolved 
metabolic network requiring information at both the compound and atom levels. Towards 
this overall goal, the ordered compound coloring identifiers derived from the 
corresponding atom coloring identifiers facilitate compound harmonization across 
metabolic databases, which is an essential first step in cross-database network integration. 
Different databases can have distinct preference in compound representations, especially 
for aromatic substructures. To overcome inconsistent aromatic representations between 
databases, we devised a pragmatic BASS method[89] for aromatic substructure detection 
that leverages the labeled aromatic substructures in KEGG. Application of BASS to KEGG 










automatic aromatic atom detection method in Indigo[87] further validated the 
comprehensiveness of our BASS aromatic substructure detection method that leverages 
KEGG’s curated aromatic substructures, and the combination of BASS and Indigo can 
achieve good performance in aromatic substructure detection. This was further augmented 
by detecting additional aromatic substructure representations in MetaCyc through ID-
based compound harmonization. In addition, compound states such as atom charge are not 
always the same between KEGG and MetaCyc. Therefore, identifiers like InChI that 
include these details to achieve an unambiguous label are not a good choice for maximizing 
cross-database compound harmonization in this situation. Furthermore, InChI cannot 
handle the compound entries that contain R-groups.  However, InChI is very useful for 
validation of the presented methods development. Simplified molecular-input line-entry 
system (SMILES) identifiers and its derivatives are not a good option, because SMILES 
and its derivatives are not guaranteed to generate a unique identifier.  Also, neither InChI 
nor SMILES deal with the unique naming of atoms that is consistent for symmetric atoms.  
While the molecular graph coloring method has similarities to molecular canonicalization 
methods[93, 101, 102], it was designed to facilitate harmonization of compounds between 
metabolic databases.  The graph coloring method is flexible in adjusting information used 
in atom coloring, which can help detect more possible matched compounds with a higher 
false positive rate. With the coloring identifiers, we were able to detect 8865 
correspondences between KEGG and MetaCyc compounds, and 5451 of them can be 
confirmed by other identifiers. In addition, commonality in EC numbers associated with 
reactions and compounds provided another avenue for both validating and predicting 
possible correspondence pairs. This method validated 1848 pairs unconfirmed by other 
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identifiers. While harmonizing compounds between KEGG and MetaCyc, we detected 
various issues and errors in the databases by coloring identifiers which are enumerated in 
the supplemental material, suggesting that this method can also be used for curation of 
current metabolic databases. Furthermore, the graph coloring method and compound 
harmonization approach can be used to integrate any metabolic database that provides a 
molfile representation of compounds, greatly facilitating future construction of more 









CHAPTER 3. HIERARCHICAL HARMONIZATION OF METABOLIC REACTIONS ACROSS 
METABOLIC DATABASES 
3.1 Introduction 
Metabolic models describe the inter-conversion of metabolites via biochemical 
reactions catalyzed by enzymes, providing snapshots of the metabolism under a given 
genetic or environmental condition[103, 104] . Metabolic models of metabolism have 
proven to be an important tool in studying systems biology and have been successfully 
applied to various research fields, ranging from metabolic engineering to system medicine 
[105-109]. Advances in analytical methodologies like mass spectroscopy and nuclear 
magnetic resonance greatly improve the high-throughput detection of thousands of 
metabolites, enabling the generation of large volumes of high-quality metabolomics 
datasets [48, 110] that greatly facilitate metabolic research. As a next major step, 
incorporating reaction atom-mappings into metabolic models enables metabolic flux 
analysis of isotope-labeled metabolomics datasets[53, 65, 69, 70], which will contribute to 
the large-scale characterization of metabolic flux molecular phenotypes and prediction of 
potential targets for gene manipulation[106]. Building reliable metabolic models heavily 
depend on the completeness of metabolic network databases. However, a relatively 
complete metabolic network, especially at an atom-resolved level, is practically not 
available [72]. 
Therefore, to construct an atom-resolved metabolic network, the very first major step 
is to integrate metabolic data from various metabolic databases without redundancy[82], 
which remains extreme labor-intensive. This is partially due to problems in the individual 
databases[111]. Common issues include non-unique compound identifiers, reactions with 
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unbalanced atomic species, and enzyme catalyzing more than one reaction[112]. Moreover, 
incompatibilities of data representations (like compound identifiers) and incomplete 
atomistic details (like the presence of R groups and lack of atom and bond stereochemistry) 
across databases are key bottlenecks for the rapid construction of high-quality metabolic 
networks[113]. Great efforts have been made to map different compound identifiers across 
metabolic databases[114, 115]. Some algorithms use logistic regression to compute the 
similarity between strings generated by concatenating a variety of compound features, 
which requires careful selection of compound features that can well characterize a string 
pair by capturing the similarity between different variations as well as underlining the 
difference between descriptions which are not synonymous[108]. Alternatively, utilization 
of unique chemical identifier independent from a particular database, like InChI[93, 116] 
or SMILES[117], have been suggested as an important step in harmonizing metabolic 
databases[118]. However, several tricky cases still remain unresolved. For example, InChI 
cannot handle the compound entries that contain R-groups. 
Our neighborhood-specific graph coloring method can derive atom identifiers for 
every atom in a specific compound with consideration of molecular symmetry, facilitating 
the construction of an atom-resolved metabolic network[119]. Furthermore, a unique 
compound coloring identifier can be generated based on the atom identifiers, which can be 
used for compound harmonization across metabolic databases. The results derived from 
the compound coloring identifiers were quite promising. However, issues like incomplete 
atomistic details were not completely handled in that prior work.  
To put this paper into context with our prior published work, we first developed the 
subgraph isomorphism detection algorithm CASS (Chemically Aware Substructure Search) 
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in 2014[89] and have made multiple improvements to this code base over the years and 
now call it BASS (Biochemically Aware Substructure Search). In developing our 
neighborhood-specific graph coloring method, we further enhanced BASS to efficiently 
detect aromatic substructures which was required for that work. In this chapter, we further 
optimized the subgraph isomorphism detection algorithm CASS (Chemically Aware 
Substructure Search)[89] to aid in the validation of generic compound pairs. In addition, 
we solved inconsistent atomistic characteristics across databases by defining a set of 
harmonization relationship types between compounds, aiming to capture chemical details 
while maintain compound pairs at various levels. Furthermore, we used the classification 
of compound pairs and EC (Enzyme Commission) numbers to harmonize metabolic 
reactions across Kyoto Encyclopedia of Genes and Genomes (KEGG) and MetaCyc 
metabolic pathway databases via establishing hierarchical harmonization relationships 
between metabolic reactions. We further made use of the atom identifiers to evaluate atom 
mapping consistency of these harmonized reactions. Through this analysis, we detected 
some issues that cause the inconsistency of reaction atom mappings both within and across 
databases. The generalization of metabolic reactions can be applied to various interesting 
topics including but not limited to predicting biotransformation of newly discovered 
metabolites[120], devising novel synthetic pathways of essential metabolites[121], and 
bridging gaps in the current metabolic network[122]. Furthermore, expanding the existing 
metabolic network by integrating other metabolic databases can be easily achieved when 
the molfile representations[76] of compounds are provided.  
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3.2 Materials and Methods 
3.2.1 Compound and Metabolic Reaction Data 
All data were downloaded directly from KEGG and MetaCyc databases. MetaCyc 
compound and reaction data downloaded from BioCyc is in version 23.0. The KEGG 
COMPOUND, KEGG REACTION and KEGG RCLASS data is from the version available 
from KEGG on April 2021 via its REST interface. KEGG RPAIR data was downloaded 
from KEGG database in 2016. 
3.2.2 Curation of molfile 
The documentation of atom stereochemistry in the molfiles is not complete. We used 
Open Babel[91] to curate the original molfiles and add stereospecific information. 
3.2.3 Identification of double bond stereochemistry 
We previously adopted a method for automated identification of double bond 
stereochemistry[90]. One limitation of this method is that only double bonds between two 
carbon atoms can be handled. For example, double bonds connected by heterogenous 
atoms, like N=C, cannot be processed by the method. Here, we designed a new algorithm 
to distinguish cis/trans stereoisomers. The same criteria are applied to assign priority to 
each group attached to the double bond. If one side of the double bond only has one group, 
this group will be prioritized. Next, the 2D plane of the compound representation is divided 
into two parts with line crossing the double bond. If the prioritized groups of both sides are 




3.2.4 Flowchart of steps in the compound and reaction harmonization process 
The flowchart of steps in compound and reaction harmonization is shown in Figure 
3.1. The initial compound pair list is composed of compound pairs detected by the loose 
compound coloring identifiers. Next, reaction harmonization is conducted with the 
compound pair list. Two criteria are obeyed in reaction harmonization: the two reactions 
should share at least one EC number and all compounds in the two reactions are paired 
unless one reaction has an extra compound entity, like H+. Apart from valid reaction pairs, 
reaction pairs with the same EC number and some unmatched compounds are also 
extracted. We hypothesized that those unmatched compounds are likely to be compound 
pairs. Validation is conducted for the unmatched compounds, and the valid compound pairs 
are added to the compound pair list. Every time the compound pair list is updated, the 
above process is repeated until no new compound pairs are discovered. 
 
Figure 3.1. Flowchart of compound and reaction harmonization. 
 
3.2.5 Validation of tautomers 
Most common form of tautomerization involves a hydrogen changing places with a 
double bond. Based on this transformation, the following steps are performed to validate if 
Valid reaction pairs: same EC 
with paired compounds. 
Compound pair list 
Reaction harmonization 
 Possible compound pairs  
Possible reaction pairs: same EC with 
some unmatched compounds 
Validation of compound pairs 
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two compounds with same chemical formula are tautomers. To eliminate the difference 
caused by single and double bonds in the structural representation, all the double bonds are 
converted into single bonds, and the subgraph isomorphism detection algorithm[89] is used 
to check if two structural representations are the same after modification. Next, double 
bonds at unmatched positions are examined. If all the mismatches are caused by possible 
tautomerization, the compound pair is considered valid. Finally, other chemical details not 
related to atoms in the changeable positions are compared to classify the relationship 
between valid pairs.  
3.2.6 Validation of generic compound pairs of compounds with different chemical 
formula. 
For two compounds A and B, the subgraph isomorphism detection algorithm[89] is 
used to verify if the graph representation of A (ignoring R and H) is contained in the graph 
representation of B. Then, each unmatched branch in B is examined if it corresponds to an 
R group in A. Compound pairs that meet both criteria are considered valid. Next, the 
chemical details (atom and bond stereochemistry) in the two compounds are compared for 
relationship type classification. If the chemical details of compound A are included in 
compound B, then A has a generic-specific relationship to B; otherwise, A and B have a 
loose relationship. 
3.2.7 Validation of compound pairs with linear and circular representations. 
The compound with changeable linear and circular structures are common in small 
molecule carbohydrate metabolites, like glucose. This conversion occurs due to the ability 
of aldehydes and ketones to react with alcohols. To validate the compound pairs with linear 
and circular representations, we first locate the bond in the circular structure that is formed 
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by connecting the C in the aldehyde (keto) group and O in the hydroxy group. The 
following steps include breaking the newly formed bond and restoring the C=O bond in 
the aldehyde (keto) group. Then, a new compound coloring identifier is generated for the 
modified circular representation. If the updated compound coloring identifiers match, the 
compound pair is considered valid.  
3.2.8 Parse of KEGG RCLASS RDM patterns. 
Based on the RDM patterns, we first identified the possible atoms that can be mapped 
to each reaction center. Then we derived the possible combinations of atoms for all the 
reaction centers for each compound. We paired cases in either compound, removed 
changed bond in the compound according to different region, and detected the maximum 
common subgraph of the remaining structures. We examined all the combinations and 
derived the optimal mappings with the maximum number of mapped atoms and least ratio 
of changed atoms. 
3.3 Results 
3.3.1 Overview of KEGG and MetaCyc databases 
The compounds in the KEGG and MetaCyc databases are summarized in Table 3.1. 
Based on the atomic composition, we divided compounds into two groups: specific 
compounds (no R group) and generic compounds (with presence of R group(s)). About 
8.02% KEGG compounds and 21.72% MetaCyc compounds contain R groups.  
Table 3.1. Summary of KEGG and MetaCyc compound databases. 
Compound Type KEGG MetaCyc 
specific compounds 16529 (91.98%) 15859 (78.28%) 
generic compounds 1441 (8.02%) 4400 (21.72%) 




According to the classification of compounds, we also categorized the atom-resolved 
metabolic reactions into two sets: specific reactions where all compounds in the reaction 
are specific compounds and generic reactions which contain at least one generic compound. 
Here, we only considered reactions with relatively complete EC numbers[97, 123] since 
consistent EC number is one essential component in reaction harmonization. From Table 
3.2, we can see that about 15% KEGG reactions and 34% MetaCyc reactions are generic 
reactions. 
Table 3.2. Summary of KEGG and MetaCyc atom-resolved metabolic reaction databases 
Reaction Type KEGG MetaCyc 
specific reactions (4-leveled EC) 6780 (75.26%) 6397 (49.93%) 
specific reactions (3-leveled EC) 886 (9.83%) 2022 (15.78%) 
generic reactions (4-leveled EC) 1244 (13.81%) 3572 (27.88%) 
generic reactions (3-leveled EC) 99 (1.10%) 822 (6.42%) 
Total 9009 (100%) 12813 (100%) 
 
We further did a simple quality check of the atom-resolved reactions in KEGG and 
MetaCyc databases (Table 3.3). KEGG contains about 7.5% incomplete reactions where 
the number of atoms on both sides of the reaction is different. For MetaCyc, less than 0.5% 
reactions have incorrect atom mappings caused by mapping different atoms of different 
elements. In addition, a large amount of reactions only have part of atoms mapped in both 
KEGEG and MetaCyc databases. This level of incompleteness prevents their effective use 
in mass balanced metabolic modeling. 








KEGG 772 (7.53%) 0 7213 (70.36%) 




3.3.2 Results of compound harmonization across KEGG and MetaCyc databases 
With the loose compound coloring identifiers generated by the neighborhood-
specific graph coloring method, about 8865 compound pairs were detected, including both 
generic and specific compound pairs [119]. However, some cases were not solved perfectly 
by the loose compound coloring identifiers. First, chemical details like atom and bond 
stereochemistry were ignored in the loose compound coloring identifies. Second, a 
compound pair can involve a generic compound and a specific compound (Figure 3.2), 
which cannot be discovered by the loosing compound coloring identifiers. The methyl 
group in KEGG compound C01042 can be a specification of the R group in MetaCyc 
compound CPD-576. What makes things more complicated is that a compound pair can be 
composed of two generic compounds with different atom composition. In Figure 3.3, even 
though both compounds contain an R group, the MetaCyc compound 3-Acyl-pyruvates can 
be regarded as a subgroup of compounds belonging to KEGG compound C00060. In 
addition, compound pairs with different structural representations, like tautomers, were 
missed by the loose compound coloring identifiers.  
                                                
 
 
Figure 3.2. Compound pair of generic and specific compounds. 
 
 







Figure 3.3. Compound pair of generic compounds. 
 
 
3.3.2.1 Harmonization of specific compounds. 
We first incorporated the chemical details, including atom stereochemistry and 
bond stereochemistry to evaluate the specific compound pairs detected by loose compound 
coloring identifiers. Incorporation of the chemical details can lead to three scenarios: 1) the 
paired compounds have the same set of chemical details; 2) the chemical details of one 
compound are the subset of the other compound; 3) the chemical details of the two 
compounds cannot be fully matched. Based on the above cases, we decided to classify the 
relationship between compound pairs as an equivalence relationship, a generic-specific 
relationship, or a loose relationship. With this classification, a compound in one database 
can be paired with multiple compounds in the other database with an appropriate 
relationship. With these improvements incorporated into specific compound harmonization 
(Table 3.4), we can see that the majority of specific compound pairs have a loose 
relationship, which is not surprising since the criteria for the loose relationship were less 
strict. Another explanation is that the chemical details for the same compound can be 
inconsistent across databases. The MetaCyc compound CPD-399 has a direct KEGG 
compound reference C03495 (Figure 3.4), but stereochemistry of some atoms in the two 
compound representations are not the same. 
KEGG: C00060 MetaCyc: 3-Acyl-pyruvates 
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Table 3.4.Harmonization of specific compound pairs.  
Relationship Type Count 
equivalence 3636 (27.99%) 
generic-specific 1712 (13.18%) 
loose 7642 (58.83%) 





Figure 3.4. Example harmonized compound pair of compounds with inconsistent chemical 
details. 
 
3.3.2.2 Harmonization of generic compounds.  
Generic compounds further complicate relationships between compounds. A 
generic compound can be related to generic and/or specific compounds (Figure 3.2 & 3.3). 
For a compound pair of two generic compounds with the same atom composition, we 
classify them based on the same criteria of specific compounds. Harmonization of generic 
compound pairs of compounds with different chemical formulas is much more complicated, 
involving detection and validation steps. All chemical identifiers fail in detecting the 
possible pairs, including the loose compound coloring identifiers. On the other hand, it will 
be very time-consuming and unnecessary to do brute-force search of all compounds across 
databases.  
Here, we made use of the metabolic reactions across databases to detect the possible 
compound pairs with a different atom composition. We first extracted reaction pairs that 
can contain at least one generic reaction and share at least one EC number. Next, 
compounds with R group(s) in one reaction were paired with all the compounds in the other 
KEGG: C03495 MetaCyc: CPD-399  
53 
 
reaction. The validation method is described in the Materials and Methods section. Results 
of harmonization are summarized in Table 3.5. Most of the generic compound pairs have 
generic-specific relationships. This may be explained by the assumption that chemical 
details in a compound with less atoms are more likely to be included in the compound 
containing more atoms.  
Table 3.5. Harmonization of generic compounds. 
Relationship Type Count 
equivalence 126 (4.72%) 
generic-specific 2543 (95.28%) 
loose 0 
Total 2669 (100%) 
 
3.3.2.3 Harmonization of compounds with changeable 
representations. 
Harmonization of compounds with changeable representation (e.g. linear vs 
circular sugar representations) also requires detection and validation. Again, metabolic 
reactions were used to detect the possible compound pairs via an iterative approach. Two 
criteria should be obeyed when extracting the reaction pairs: 1) the two reactions should 
share at least one EC number; 2) at least a pair of compounds in the two reactions can be 
matched. For those unmatched compounds with the same chemical formula, they will be 
added to the possible list. The validation methods are described in the Materials and 
Methods section. About 45 such compound pairs were discovered after two rounds of 
iteration (Table 3.6).  
Table 3.6. Harmonization of compounds with changeable representations. 
Relationship Type Count 
equivalence 20 (44.44%) 
generic-specific 0 
loose 25 (55.56%) 




3.3.2.4 Summary of compound harmonization. 
All compound pairs detected above were summarized in Table 3.7. In total, 15,704 
compound pairs were discovered, and more than 80% of them were specific compound 
pairs, roughly in agreement with the proportion of generic compounds in the database. 
More importantly, about 2,669 generic compound pairs were detected, which cannot be 
achieved by any existing chemical identifier.   
Table 3.7. Summary of compound harmonization between KEGG and MetaCyc. 
Compound Pair Type Count 
specific compound pairs 12990 (82.72%) 
generic compound pairs 2669 (16.99%) 
changeable compound pairs 45 (0.29%) 
Total 15704 (100%) 
 
3.3.3 Results of reaction harmonization across KEGG and MetaCyc databases. 
With the harmonized compounds, we performed reaction harmonization across 
KEGG and MetaCyc databases. Two criteria should be followed in reaction harmonization: 
1) the two reactions should share at least an EC number; and 2) all compounds in the two 
reactions should be paired unless one reaction has an extra compound entity, like H+. 
Reaction pairs were further categorized into the following three relationship types based 
on the classification of their compound pairs: 1) equivalence relationship when a reaction 
pair included only equivalently paired compounds; 2) generic-specific relationship when a 
reaction pair only included equivalently paired compounds and at least one generic-specific 
compound pair that are consistently in the same general-to-specific direction; 3) loose 
relationship when a reaction pair included loosely paired compounds or generic-specific 
paired compounds with inconsistent general-to-specific direction.  
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We first harmonized the specific metabolic reactions where both reactions are 
specific reaction (Table 3.8). We can see that reaction pairs in group 3 take up more than 
70%, which is quite consistent with the classification of specific compound pairs. About 
60% of specific compound pairs are loosely matched (Table 3.4), and a reaction pair only 
requires one loosely matched compound pair to be classified into group 3.  
Table 3.8. Harmonization of specific reactions between KEGG and MetaCyc. 
Relationship Type Count 
equivalence 718 (24.00%) 
generic-specific 68 (2.27%) 
loose 2205 (73.72%) 
Total 2991 (100%) 
 
We also analyzed the generic reaction pairs where at least one reaction is generic. 
Above 70% generic reaction pairs are in group 2 (Table 3.9), which can also be well 
explained by the previous result that around 95% generic compound pairs have a generic-
specific relationship. 
Table 3.9. Harmonization of generic reactions between KEGG and MetaCyc. 
Relationship Type Count 
equivalence 29 (6.03%) 
generic-specific 344 (71.51%) 
loose 108 (22.45%) 
Total 481 (100%) 
 
Since the EC information is not very complete in both databases, some reaction 
pairs can be ignored due to the mismatch or miss of the last level EC. To avoid missed 
pairs, we relaxed the first criterion in reaction harmonization to “the two reactions should 
have at lease a pair of EC numbers that share the first 3 levels”. The newly discovered 
reaction pairs are summarized in Table 3.10, including both specific and generic reaction 
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pairs. Either mismatch or miss of last EC occur in some reaction pairs. Specific examples 
are shown in Figure 3.5 & 3.6. 
Table 3.10. Loose harmonization of reactions between KEGG and MetaCyc. 
Relationship Type Count 
equivalence 49 (12.76%) 
generic-specific 96 (25.00%) 
loose 239 (62.24%) 





Figure 3.5. Reaction pair with mismatch of last EC number. 
A) MetaCyc reaction 6.2.1.34-RXN with EC number 6.2.1.34 
(https://metacyc.org/META/NEW-IMAGE?object=6.2.1.34-RXN&&redirect=T); B) 
















Figure 3.6. Reaction pair with missing 4th-level EC number designation. 
A) MetaCyc reaction ACETCAPR-RXN with EC number 2.6.1.- 
(https://metacyc.org/META/NEW-IMAGE?object=ACETCAPR-RXN&&redirect=T); 
B) KEGG reaction R04029 with EC number 2.6.1.65 
(https://www.genome.jp/entry/R04029). 
 
The results of reaction harmonization are shown in Table 3.11. Overall, 3,856 
reaction pairs were detected via EC numbers and integrated compound pairs. The majority 
of reaction pairs are specific. About 10% of reactions pairs can be missed due to incomplete 
and inconsistent EC numbers. 
Table 3.11. Summary of reaction harmonization between KEGG and MetaCyc. 
Relationship Type Count 
specific 2991 (77.57%) 
generic 481 (12.47%) 
loose EC 384 (9.96%) 
Total 3856 (100%) 
 
3.3.4 Comparison of KEGG RCLASS and RPAIR data 
For the KEGG database, the RCLASS data describes the chemical transformation 
of substrate-product in the RDM pattern [124]. A RDM description can be divided into 





order to distinguish functional groups and microenvironment of atoms, KEGG classified 
atomic species of C, N, O, S, and P into 68 types (KEGG atom types)[88], which are 
implemented in the RDM description. As shown in Figure 3.7, The RCLASS entry 
RC00003 contains one RDM description. The S atom is the reaction center, the C1a in the 
first substructure belongs to the different region, and those C1b atoms are in the matched 
region. Based on the RDM pattern, we derived the atom mappings for specific reactant-
product compound pairs based on a common graph isomorphism search between the two 
compounds limited by RDM description. We successfully parsed atom mappings for 
10,212 (out of 10,313) compound pairs. There are 76 compound pairs that cannot be 
deciphered due to the incorrect or missing descriptions of reaction centers. For complicated 
compound pairs with multiple reaction centers, each reaction center can be mapped to 
several different atoms, which in a few instances causes a serious combinatorial issue that 
is impossible to address in a reasonable amount of time. An example is shown in Figure 
3.8. Roughly 1013 possible cases can be derived based on the RDM descriptions. In total, 
25 compound pairs cannot be processed owing to this combinatorial problem (Table 3.12). 
KEGG used to archive the atom mappings between the reactant-product compound pairs 
in the RPAIR database, where the mapped atoms are specified by the atom numbering for 
a compound pair. Here, we evaluated the atom mappings derived from RCLASS and an 
older version of KEGG RPAIR. The majority (great than 86%) of atom mappings between 
RCLASS and RPAIR are the same (Table 3.13). To further validate the results, we 
calculated the fraction of atom mappings with changed local bonded chemical environment 
across the mapping (i.e., atom mappings with changed one-bond atom color) in terms of 
the total number of mapped atoms in the reaction. The expectation is that this fraction 
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represents the fraction of reaction center atoms present where a chemical bond is changed 
or broken. Then, we generated a scatter plot of changed local atom color fraction for KEGG 
RPAIR versus RCLASS atom mappings. From Figure 3.9 A, we can see that the majority 
compound pairs have the same fraction of changed local atom color (concentrated on the 
diagonal line). In addition, more atom mappings derived from RPAIR have a higher ratio 
of changed atoms. We figured out that the majority of the inconsistency is due to the 
interchangeable mappings of resonant atoms, like the O atoms in the carboxyl group 
(Figure 3.10). After further curation to handle resonant atoms (Table 3.14), about 94% 
compound pairs have the same atom mappings. From Figure 3.9 B, we can see that quite 
large portion of compound pairs with higher ratio of changed atoms in RPAIR disappear. 
The remaining 557 inconsistent mappings appear to come from two different issues. One, 
more than 93% of the remaining inconsistent mappings (517 out of 557) are likely caused 
by the updating of the KCF (molfile like) files or associated molfiles in KEGG database 
from continual curation. For example, the RDM description for compound pair 
C01255_C02378 has been updated in the RCLASS (Figure 3.11). We also plotted the 
changed one-bond atom color fraction for compound pairs with RDM update (Figure 3.9 
C). Compound pairs in either RCLASS or RPAIR can have higher changed atom ratio. The 
fraction of changed local atom color appears to equally distributed above and below the 
diagonal red line, which is interesting since the update of RDM descriptions is a correction 
process in KEGG database and may reflect both changes in specific mapped atoms and 
changes in the overall proportion of atoms mapped. Two, we found that a compound 
representation can vary across different compound pairs. Therefore, we hypothesize that a 
lack of synchronization between compound and compound_pair representations over time 
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has caused the observed atom mapping inconsistencies detected in most of the other 40 
compound pairs. For this part, RPAIR compound pairs show an increased fraction of 
changed local atom color (Figure 3.9 D) versus its equivalent RCLASS, demonstrating that 
this metric has value in evaluating atom mappings. 
 
Figure 3.7. Example of RCLASS entry. 



















Figure 3.8. RCLASS with combinatorial issue caused by multiple possible mappings of 
RDM descriptions.  
A) RDM description of RCLASS RC02715 (https://www.genome.jp/dbget-
bin/www_bget?rc:RC02715); B) Compound pair C01054_C08626 that follows the 























Table 3.12. Hardly interpretable compound pairs. 




























Table 3.13. First-round evaluation of atom mappings of compound pairs between KEGG 
RCLASS and RPAIR. 
Condition Count 
same atom mappings 8017 (86.1%) 
inconsistent atom mappings 1294 (13.9%) 




       
       
Figure 3.9. Scatter plot of changed one-bond atom color fraction for KEGG RCLASS 
versus RPAIR atom mappings in paired compounds. 
(A) All compound pairs before correcting resonant atoms; (B) All compound pairs after 
correcting resonant atoms; (C) Compound pairs with inconsistent atom mappings caused 





Figure 3.10. Example of atoms with interchangeable mappings. 
KEGG RPAIR maps atom 1 in C03618 to atom 2 in C06030 and atom 2 in C03618 to atom 
















Table 3.14. Second-round evaluation of atom mappings of compound pairs between KEGG 
RCLASS and RPAIR. 
Condition Count 
same atom mappings 8333 (95.19%) 
inconsistent atom mappings 422 (4.8%) 








Figure 3.11. Comparison of KEGG RCLASS and RPAIR description for compound pair 
C01255 and C02378. 
A) Compound C01255 and C02378 (https://www.kegg.jp/kegg-
bin/rpair_image?entry=RC00090&cpair=C01255_C02378); B) KEGG RCLASS 
description for the compound pair (https://www.genome.jp/dbget-
bin/www_bget?rc:RC00090); C) KEGG RPAIR description for the compound pair along 








3.3.5 Evaluation of atom mappings between KEGG and MetaCyc databases.  
The atom mappings for each reaction in the MetaCyc database are specified based 
on the atom numbering of each compound in their molfile representation. For the KEGG 
database, we used the atom mappings for compound pairs parsed from the RCLASS entries. 
Here, we evaluated the atom mappings in about 3000 specific reaction pairs with the same 
compound representations (Table 3.15). About 88% of the reaction pairs have consistent 
atom mappings between the two databases. A consistent example is shown in Figure 3.12. 
Table 3.15. Evaluation of atom mappings between KEGG and MetaCyc. 
Condition Count 
same atom mappings 2685 (88.0%) 
inconsistent atom mappings 366 (12.0%) 





Figure 3.12. Example of reaction pair with the same atom mappings. 
Reaction pair MetaCyc 1.1.1.168-RXN (https://metacyc.org/META/NEW-
IMAGE?object=1.1.1.168-RXN&&redirect=T) and KEGG R03155 




















We also generated a scatter plot of changed atom color fraction between paired 
KEGG and MetaCyc reactions (Figure 3.13 A). For some reactions, only part of the 
compounds are mapped in either database (Table 3.3). For MetaCyc, atoms are normally 
mapped at a reaction level. Since the KEGG RCLASS database maps atoms at a compound 
level, multiple RCLASS atom mappings must be evaluated together for a given KEGG 
reaction. We also just visualized paired reactions with inconsistent atom mappings (Figure 
3.13 B). We can see that the MetaCyc reactions have a higher ratio of changed local atom 
color. However, the number of mapped atoms in the paired reactions are not always the 
same, which can cause the fraction of changed local atom color can deviate from the 
diagonal. This issue makes a direct interpretation for specific reaction pairs more difficult, 
but the observed trend above the diagonal has interpretable value.  
Through these comparisons, we see that both databases can contain distinct issues with 
their atom mappings. Some MetaCyc reactions can have incorrect atom mappings. An 
example is shown in Figure 3.14. For some KEGG reactions with single compound 
involving in several compound pairs, one atom can be mapped to multiple atoms and leave 
some atoms unmatched. For the KEGG reaction R10579 shown in Figure 3.15 A, based on 
the RDM descriptions in the two compound pairs (Figure 3.15 B & 3.15 C), atom 1 in 
compound C00251 is mapped to atom 1 in compound C00022 and atom 1 in compound 
C00578, leaving atom 2 in C00251 unmapped. Compared with the corresponding MetaCyc 
reaction RXN-14940 (Figure 3.16), the RDM description of KEGG RCLASS RC03212 
appears incorrect. The harmonized reactions with different atom mappings are shown in 
Supplementary Spreadsheet 3.1.  
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Figure 3.13. Scatter plot of changed one-bond atom color fraction for KEGG versus 
MetaCyc atom mappings in paired reactions. 
Lighter colors represent higher overlapped point density. (A) All paired reactions are 























Figure 3.15. Example of KEGG reaction with incorrect mappings.  
A) KEGG reaction R10579 (https://www.kegg.jp/entry/R10597); B) KEGG RCLASS 















Effective integration of compound and reaction from various sources is hard to 
achieve due to incomplete and inconsistent atom-level and bond-level details, like R groups 
and stereochemistry, across databases. First, we categorized compounds into specific and 
generic compounds based on the presence of R groups. Meanwhile, metabolic reactions 
were classified into specific and generic reactions according to the presence of generic 
compounds. To overcome inconsistent atomistic characteristics, a set of relationships 
between compounds were defined to both keep chemical details and conserve compound 
pairs at various levels. According to the degree of consistency, compound pair relationships 
are classified into three types: equivalence, generic-specific, and loose relationships. The 
majority (around 60%) of specific compound pairs have loose relationships, confirming 
the inconsistent issues in the databases to some extent. To our knowledge, no chemical 
identifier can be used to directly harmonize generic compounds across databases. Here, we 
further optimized a subgraph isomorphism detection algorithm to validate generic 
compound pairs. We first made use of the metabolic reactions to discover possible generic 
compound pairs. After validation, 2669 generic compound pairs remained. In addition, we 
developed pragmatic methods to validate tautomers and compounds with linear and 
circular representations. We discovered 45 compound pairs of compounds with the same 
chemical formula but fundamentally different structures, for example linear versus 
circularized chemical representations. In total, 15,704 harmonized compound pairs were 
detected, which dwarfs our prior best published compound harmonization result of 8865 
harmonized compound pairs and 5681 harmonized compound pairs identified by prior 
identifiers and methods. Next, we mapped atom-resolved metabolic reactions across 
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KEGG and MetaCyc via compound pairs and EC numbers. Reaction pairs were also 
catalogued into hierarchical relationships in accordance with the classification of 
compound pairs. About 3856 harmonized reaction pairs were detected, and 10% of them 
can be missed by mismatched EC numbers (Figure 3.5 & 3.6), strongly suggesting that 
curation of EC numbers is of great importance in reaction harmonization. A prior 
systematic comparison of KEGG and MetaCyc had detected only 1961 shared reactions; 
however, this comparison was published in 2013[125]. The BRaunschweig ENzyme 
Database (BRENDA) indicates in a 2019 paper that 6115 reactions are harmonizable 
between KEGG and MetaCyc[126]. However, BRENDA uses a combination of text 
mining and prediction algorithms to build their database from primary literature, likely 
making their harmonization results not as chemically specific as the results presented here 
which directly analyzes molfiles provides by KEGG and MetaCyc. 
Furthermore, we made use of the atom identifiers derived from our neighborhood-
specific graph coloring method to evaluate the consistency of atom mappings across 
harmonized reactions. About 88% of reaction pairs have consistent atom mappings. For 
the 12% of harmonized and comparable reactions that are inconsistent, we do not have 
ground truth for determining which version of the reaction is correct. However, the fraction 
of changed local atom color provides a uses metric for suggesting which version has higher 
confidence. Additionally, given that these reaction descriptions represent reactions across 
thousands of organisms, it is possible that both versions are correct in different organisms. 
Additionally, we determined that both databases contain issues leading to inconsistency. 
For example, atoms in some MetaCyc reactions are not mapped correctly. For KEGG, we 
detected unsynchronized atom numbering in the older KEGG RPAIR representation, 
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which is likely the reason that KEGG removed RPAIRS from their public version of the 
database. In contrast, the KEGG RCLASS provides a concise RDM representation of 
reaction atom mappings between a reaction-product compound pair, which appears highly 
resistant to consistency errors. This resistance to consistency error is due to a decoupling 
of the atom mappings from the specific atom order in the molfile representations. This 
allows the molfile representations to be minorly updated without having to update the RDM 
descriptions. However, there are also some issues with RDM descriptions. About 76 
compound pairs cannot be parsed due to the incorrect description of reaction centers, and 
parsed compound pairs can be unreasonable at reaction level. In addition, a few KEGG 
RCLASS entries are computationally difficult to decipher due to a combinatorial issue 
caused by the several factors: multiple reaction centers in a single reaction, symmetric 
compounds, and reaction descriptions involving multistep reactions. This combination of 
factors introduces a large number of possibilities with matching a list of RDM descriptions 
to specific reaction center atoms. One way to prevent this combinatorial problem is to 
represent multiple reaction center atoms with their associated difference atoms and match 
atoms within a paired substructure representation instead of a list of RDM descriptions. 
Figure 3.15 B illustrates this paired substructure representation for the KEGG RCLASS 
RC02148. This kind of paired RDM substructure representation would allow the use of an 
efficient subgraph isomorphism detection method to derive the atom mappings and could 
be represented as a pair of molfiles along with a mapping of atoms between the two molfiles, 
all stored within a single sdfile. Additionally, our compound harmonization method for 
harmonizing changeable compound pairs would be useful for updating the paired RDM 
substructures when the compound representations dramatically change.  
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In addition, the methods we developed can be easily applied to integrate other 
metabolic databases that provide molfile representations of compounds, facilitating the 
expansion of the existing metabolic networks. Moreover, this hierarchical framework for 
relating compounds and reactions is a possible first step towards creating a systematic 
organization of all reaction descriptions at a desired chemical specificity to fit a given 
application. Such a systematic organization of reaction descriptions would augment the 
current Enzyme Commission number system and be useful to a wide range of possible 
applications from metabolic modeling, metabolite and reaction prediction, and network 




CHAPTER 4. MOIETY MODELING FRAMEWORK FOR DERIVING MOIETY ABUNDANCES 
FROM MASS SPECTROMETRY MEASURED ISOTOPOLOGUES 
4.1 Introduction 
Recent work indicates that many human diseases involve metabolic reprogramming 
that disturbs normal physiology and causes serious tissue dysfunction[127]. Advances in 
analytical technologies, especially mass spectroscopy (MS) and nuclear magnetic 
resonance (NMR), have made metabolic analysis of human diseases a reality[48]. Stable 
isotope tracing is a powerful technique that enables the tracing of individual atoms through 
metabolic pathways. Stable isotope-resolved metabolomics (SIRM) uses advanced MS and 
NMR instrumentation to analyze the fate of stable isotopes traced from enriched precursors 
to metabolites, providing richer metabolomics datasets for metabolic flux analyses. NMR 
can measure isotopomer-specific metabolite data, but is typically limited by sensitivity.  
Often a single piece of NMR data only provides information on the presence of stable 
isotopes in just a part of a metabolite, which represents a partial isotopomer. In some cases, 
multiple partial isotopomer information can be interpreted in terms of a full isotopomer.  
MS can measure isotopologue-specific data; however, an isotopologue represents a set of 
mass-equivalent isotopomers. Comprehensive metabolic analysis often relies on MS 
metabolic datasets or a combination of MS and NMR metabolic datasets. Even though 
large amounts of metabolomics datasets have been generated recently, it is still a big 
challenge to acquire meaningful biological interpretation from MS raw data, especially for 
complex metabolites composed of multiple subunits or moieties.  
To better interpret complex isotopologue profiles of large composite metabolites, 
both quantitative analysis as well as detailed modeling are required. Several methods have 
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been developed for quantitative flux analysis of specified pathways based on the stable 
isotope incorporated data, like the elementary metabolite units (EMU) framework[56]. 
These methods rely heavily on well-curated metabolic networks to accomplish the 
metabolic flux analysis. However, models of cellular metabolism, even for human, are far 
from complete.  
To deconvolute the relative isotope incorporation fluxes of complex metabolites, first 
a plausible model of isotope incorporation should be built based on a relevant metabolic 
network, which is often incomplete.  For example, the complex metabolite uridine 
diphosphose N-acetyl-D-glucosamine (UDP-GlcNAc), illustrated in Figure 4.1 A, has four 
distinct moieties in which 13C isotopes incorporate through a metabolic network from an 
isotope labeling source like 13C-labeled glucose.  Based on the well-studied metabolic 
pathways that trace from glucose to UDP-GlcNAc in human metabolism, the expected 
(expert-derived) moiety model of 13C isotope incorporation from 13C-labeled glucose is 
illustrated in Figure 4.1 B, which includes 13C incorporation states for each moiety.  For 
example, the g6 state represents the incorporation of 13C6 into the glucose moiety.  
Furthermore, the sum of moiety states for a given moiety is equal to 1.  With this moiety 
model, a UDP-GlcNAc isotopologue profile can be deconvoluted into relative 13C isotope 
incorporation into each UDP-GlcNAc moiety: glucose, ribose, uracil, and acetyl.  The 
deconvolution occurs by minimizing an objective function that compares calculated 
isotopologues based on moiety isotope incorporation (enrichment) state parameters from 
the model to the directly observed, experimentally-derived isotopologues.  From a 
mathematics perspective, the minimization represents a highly non-linear inverse problem, 
since the experimental intensities are compared to calculated values from nonlinear 
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equations that use model parameters being optimized (Figure 4.1 B).  With a time-series of 
isotopologue profiles, relative isotope fluxes for each moiety can be derived and used for 
the interpretation of isotope flux through specific metabolic pathways associated with each 
moiety.  However, when multiple models are plausible, development of a robust model 
selection method is essential for successful isotopologue deconvolution, especially for non-
model organisms.  This basic approach to isotopologue deconvolution was demonstrated 
in a prototype Perl program called GAIMS for the metabolite UDP-GlcNAc using a MS 
isotopologue profile derived from a prostate cancer cell line[68]. This demonstration 
derived relative 13C isotope fluxes for several converging biosynthetic pathways of UDP-
GlcNAc under non-steady-state conditions. This demonstration also inspired the 
development of MAIMS, a software tool for metabolic tracer analysis[128], which further 
validates the robustness of the moiety model deconvolution method. However, the MAIMS 
software handles only 13C single isotope tracer data and does not address model selection, 





Figure 4.1. Example complex metabolite UDP-GlcNAc and associated expert-derived 
moiety model.  
A) Major human metabolic pathways leading from glucose to the four moieties of UDP-
GlcNAc. B) The representative moiety model is based on the expected metabolic tracing 
from 13C-labeled glucose to UDP-GlcNAc, with the exception of one carbon in the uracil 
moiety that traces from carbon dioxide. The moiety states variables are identified by a 
lowercase moiety letter followed by a number representing the 13C isotope content. The 
moiety state variables (model parameters) are used to calculate specific components of the 
relative isotopologue intensity. 
 
In addition, the simultaneous use of multiple stable isotopes in SIRM experiments 
can provide much more data than a single tracer. However, incorporation of multiple stable 
isotopes also complicates the analysis of metabolite isotopologue profiles, which limits 
most of the current isotope tracer experiments to a single tracer. The lack of data analysis 
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tools greatly impedes the application of the multiple-labeled SIRM experiments. Therefore, 
we have developed a new moiety modeling framework for deconvoluting MS isotopologue 
profiles for both single and multiple-labeled SIRM MS datasets. This moiety modeling 
framework not only solves the non-linear deconvolution problem, but also facilitates 
selection of the optimal model describing the relative isotope fluxes for a specific 
metabolite(s) from a set of plausible models.  
4.2 Implementation 
4.2.1 Overview of the moiety modeling framework 
The workflow of the moiety modeling framework is composed of four major steps, 
model and data representation, model (parameter) optimization, analysis of optimization 
results, and model selection (Figure 4.2). For the model and data representation step, the 
moiety_modeling package creates an internal representation of a moiety model from a 
given JSONized moiety model description (see Figure 4.3). In this representation 
illustrated by a unified modeling language (UML) class diagram in Figure 4.4, the package 
first dissembles a complex metabolite into a list of moieties, i.e. metabolic subunits. Each 
moiety may contain different number of labeling isotopes, representing the flow of isotope 
from the labeling source to the moiety. A moiety with a specific number of labeled isotopes 
is represented as an isotope enrichment state of the moiety (i.e. moiety state). As specified 
in the JSONized model description, non-default mathematical relationships may exist 
between moiety states, even from different moieties and/or molecules. Molecules, their 
moieties, the possible moiety states, and relationships between moiety states work together 
to represent a particular moiety model, and the proportion for each possible moiety state is 
78 
 
an optimizable parameter of the model. Each mass spectrum’s worth of isotopologue data 
is represented as a separate dataset, which holds the set of isotopologues associated with 
each molecule.  Typically, multiple mass spectra are included.  Often each mass spectrum 
represents a single time point in a time series experiment. 
 
 





































    “name”: “ribose”, 
    “nickname”: “r”, 
    “ranking”: 1, 
“maxIsotopeNum”: {“13C”: 5}, 
“isotopeStates”: [1, 129], 






“moieties”: [{“py/id”: 13}, …],  
“standardStates”: {“13C0”: [ [ “ribose[13C0]”, “glucose[13C0]”, “acetyl[13C0]”, 
         “uracil[13C0]”]], “13C10”: [ [“ribose[13C0]”, “glucose[13C6]”, “acetyl[13C2]”,  
         “uracil[13C2]”], [“ribose[13C5]”, “glucose[13C0]”, “acetyl[13C2]”,  
         “uracil[13C3]”], …], …}, 
“allStates”: [ “13C0”, “13C1”, “13C2”, “13C3”, “13C4”, “13C5”, “13C6”, “13C7”, 
“13C8”,  
         “13C9”, “13C10”, “13C11”, “13C12”, “13C13”, “13C14”, “13C15”, “13C16”, 
“13C17”], 




“moiety”: {“py/id”: 13}, 
“moietyState”: “13C0”, 
“varName”: “glucose[13C0]”, 














Figure 4.4. A unified modeling language (UML) class diagram of a Moiety Model. 
 
 
The next major step, moiety model (parameter) optimization, involves deriving an 
optimal set of model parameters, i.e. moiety state fractional abundances (𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑖 
for moiety j and state i) that are used to calculate relative isotopologue abundances (Ix,calc 
from Equation 1) that best match experimental isotopologue profiles (Ix,obs) as compared 
by an objective function (see Table 4.1).  In Equation 1, ica is a component of the 
isotopologue intensity with an isotope content x. Figure 4.1B lists these isotopologue 
components for each isotopologue based on the expert-derived moiety model.  
 
 
𝐼𝑥,𝑐𝑎𝑙𝑐 = ∑ 𝑖𝑐𝑎𝑖𝑐𝑎∈𝐼𝐶𝑥   ;  𝐼𝐶𝑥 = {𝑖𝑐𝑣|𝑖𝑠𝑜𝑡𝑜𝑝𝑒_𝑐𝑜𝑛𝑡𝑒𝑛𝑡(𝑖𝑐𝑣) = 𝑥}  ; 𝑖𝑐𝑣 = ∏ 𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑣𝑗𝑗               (1) 
 
Table 4.1. Different forms of objective function 
Loss function Equation 
Absolute difference Σ|Ix,obs – Ix,calc| 
Log difference Σ|log(Ix,obs) – log(Ix,calc)| 
Square difference Σ(Ix,obs – Ix,calc)2 
 
The moiety_modeling package implements several optimization methods, 
including a combined simulated annealing and genetic algorithm (SAGA) based on the 
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‘Genetic Algorithm for Isotopologues in Metabolic Systems’ (GAIMS) Perl 
implementation[68] , a truncated Newton algorithm (TNC)[130], a  SLSQP algorithm 
using Sequential Least Squares Programming[131], and a L-BFGS-B algorithm[132].  For 
the latter three algorithms ‘TNC’, ‘SLSQP’, and ‘L-BFGS-B’, the moiety_modeling 
package uses the implementation from the scipy.optimize Python module. In addition, we 
have the option to optimize the datasets together or separately.  
The third major step involves the analysis of the results from the model 
optimization.  The moiety_modeling package provides facilities for generating summative 
statistics and graphical visualizations for a set of optimizations performed on one or more 
moiety models.  The final major step, model selection, tries to find the model that best fits 
the experimental isotopologue profiles from a set of provided moiety models that have been 
optimized in step two. Several forms of the Akaike information criterion (AIC)[133] and 
Bayesian information criterion (BIC)[134] are used as the estimator of the relative quality 
of moiety models for the set of isotopologue data. 
4.2.2 The moiety_modeling Python package implementation 
As shown in Figure 4.5, the moiety_modeling Python package consists of several 
modules: ‘model.py’, ‘modeling.py’, ‘analysis.py’, and ‘cli.py’. The ‘model.py’ module 
contains class definitions for the basic elements in the moiety model. It is composed of 
‘Moiety’, ‘Relationship’, ‘Molecule’ and ‘Model’ classes. The ‘Moiety’ object represents 
a specific moiety, the labeling isotopes present in the moiety, and their corresponding states 
within the moiety. The ‘Relationship’ class describes the non-default mathematical 
dependencies between moiety states, where the default dependency for a given moiety is 
that the sum of its states is equal to 1 (see Figure 1B for example default relationships). A 
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‘Molecule’ object represents an individual metabolite made up of a list of ‘Moiety’ objects. 
The ‘Model’ class simulates the flow of isotope from labeling sources into each moiety of 
specific metabolites, which is initialized by lists of ‘Moiety’ objects, ‘Molecule’ objects, 
and ‘Relationship’ objects. A moiety model is generated and stored in a JSONized 
representation using the jsonpickle Python package[135]. This JSONized representation 
(see Supplementary Data 4.1), stored in a file, is then used as the input file for later model 
optimizations. The ‘modeling.py’ module is responsible for model optimization. It is 
composed of the ‘Dataset’ class, several model optimization classes, and the 
‘OptimizationManager’ class. The ‘Dataset’ class organizes a single MS isotopologue 
profile dataset into a dictionary-based data structure. ‘Dataset’ objects are stored in a 
JSONized representation (see Supplementary Data 4.2) and used as the input for later 
model optimizations.  Currently, no relationship between Dataset objects like a time-
dependence is captured. In the abstract ModelOptimization class, we included several 
different objective functions (see Table 4.1).  In addition, there are four specific model 
optimization classes in the ‘modeling’ module that utilize different optimization methods 
and approaches for combining datasets. The ‘SAGAoptimization’ and 
‘SAGAseparateOptimization’ classes use the SAGA-optimize Python package described 
in the next section for either combined optimization of model parameters across all datasets 
or separate optimizations of model parameters for each dataset. ‘ScipyOptimization’ and 
‘ScipySeparateOptimization’ classes make use of optimization methods (‘TNC’, ‘SLSQP’, 
and ‘L-BFGS-B’) in the scipy.optimize module to conduct optimizations in either a 
combined or separate manner. The ‘OptimizationManager’ class is responsible for the 
management of the optimization process based on the input optimization parameters. The 
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results for a model optimization are stored in a JSONized representation (see 
Supplementary Data 4.3) for further analysis. A text file is used to store the filepaths to all 
of the optimized models with certain optimization parameters. The filepath file is then used 
as the input for the ‘analysis.py’ module. The ‘analysis.py’ module has five classes: 
‘ResultsAnalysis’, ‘ModelRank’, ‘ComparisonTable’, ‘PlotMoietyDistribution’ and 
‘PlotIsotopologueIntensity’. The ‘ResultsAnalysis’ class is responsible for generating 
standard statistics from the results for a set of optimizations for a given model. The mean, 
standard deviation, minimum, and maximum value of each model parameter are calculated 
from a set of model optimizations performed on the same model. The calculated 
isotopologue intensities and their statistics based on the sets of optimized parameters are 
also generated. Furthermore, several quality estimators of each model, including different 
forms of the ‘AIC’ (Table 4.2), are computed for model selection. The AIC tends to select 
the model that has too many parameters when the sample size is small, leading to 
overfitting. The sample size corrected AIC (AICc) was developed to address this 
overfitting problem[136]. The Bayesian information criterion (BIC) is another commonly 
used criterion for model selection[137]. The ‘ResultsAnalysis’ objects with results for each 
model are stored in a JSONize representation (see Supplementary Data 4.4) for further 
analysis, along with a text report for readability. Also, an analysis filepath file containing 
the filepaths to the analysis JSON files of all models with the same optimization parameters 
is created. Next, the ‘ModelRank’ class object uses this analysis filepath file to compare 
and select the model that best reflects the observed isotopologue profile. The 
‘ComparisonTable’ class compares the model selection results with different optimization 
parameters. The ‘PlotMoietyDistribution’ class and ‘PlotIsotopologueIntensity’ class are 
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responsible for the visualization of the optimization results for a set of optimizations 
performed on a single model. The ‘cli.py’ module provides the command-line interface to 
perform model optimization, model optimization analysis, and model selection, which is 









Figure 4.5. Organization of the moiety_modeling package represented with UML 
diagrams.  
A) UML package diagram of the moiety_modeling Python library; B) Subpackage 
dependencies diagram; C) UML class diagram of the ‘modeling.py’ module with 
dependency relationships; D) UML class diagram of the ‘analysis.py’ module, which 








Table 4.2. Different forms of a model selection estimator 
Selection Criterion Equation 
Akaike Information Criterion (AIC) 2k + nln(RSS/n) 
Sample size corrected AIC (AICc) AIC + (2𝑘2 + 2k)/(n − k − 1) 
Bayesian Information Criterion (BIC) nln(RSS/n) +  kln(n) 
k is the number of parameters. 
n is the number of data points. 




4.2.3 SAGA-optimize Python package implementation 
The SAGA-optimize Python package is a novel type of combined simulated 
annealing and genetic algorithm[68] used to find the optimal solutions to a set of 
parameters based on the minimization of a given energy (objective) function calculated 
using the set of parameters.  In this context, the energy function represents a comparison 
of calculated and experimentally-observed isotopologue relative intensities, with the 
calculated intensities based on the moiety model parameters being optimized. As shown in 
Figure 4.6, it is composed of ‘ElementDescription’, ‘Guess’, ‘Population’ and ‘SAGA’ 
classes. An ‘ElementDescription’ object describes an individual parameter of the moiety 
model.  In the expert derived moiety model (Figure 4.1B), the g6 model parameter would 
be represented by a single ‘ElementDescription’ object.  The ‘ElementDescription’ object 
is bound by a range and several mutation methods are available to change the value of the 
‘ElementDescription’ object. A ‘Guess’ object contains lists of all the parameters 
(‘ElementDescription’ objects) and their corresponding values for a particular moiety 
model. In addition, it also stores the energy calculated based on this set of parameters. A 
‘Population’ object contains information of a list of ‘ElementDescription’ objects, a list of 
‘Guess’ objects, the range of each ‘ElementDescription’ among all the ‘Guess’ objects, the 
highest and lowest energy for the list of ‘Guess’ objects, and the best ‘Guess’ object. The 
‘ElementDescription’, ‘Guess’ and ‘Population’ classes are the building blocks of the 
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‘SAGA’ class, which is the main class that provides the interface for optimization. 
Furthermore, several distinct crossover functions are available for creating new Guess 
objects from the cross-over of two other Guess objects. 
 
 
Figure 4.6. ‘SAGA-optimize’ package represented with a UML class diagram with 
dependencies. 
4.3 Results 
4.3.1 The package interface 
The moiety_modeling package can be used in two main ways: (i) as a library within 
Python scripts for accessing and manipulating moiety models and isotopologue datasets 
stored in JSON files, or (ii) as a command-line tool to perform model optimization, model 
analysis, and model selection.  
To use the moiety_modeling package as a library within Python scripts, it should 
be imported with a Python program or an interactive interpreter interface. Next, ‘Moiety’, 
‘Relationship’ and ‘Molecule’ objects can be created to construct a moiety model. ‘Dataset’ 
objects are also built with the moiety_modeling package. Table 4.3 summarizes common 
patterns for using moiety_modeling package as a library in construction of a moiety model 
and related datasets. 
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The moiety_modeling package also provides a simple command-line interface to 
perform model optimization, selection, and visualization. Figure 4.7 shows version 1.0 of 
the command-line interface, and Table 4.4 summarizes common pattern for using 
moiety_modeling as a command-line tool. The common patterns for using SAGA-optimize 
as a library are shown in Table 4.5. 
Table 4.3. Common creation patterns for the moiety_modeling library 
Entity Example 
Moiety 
glucose = moiety_modeling.Moiety(‘glucose’, {‘13C’: 6}, isotopeStates={‘13C’: [1, 3, 5]},  nickname= ‘g’) 
acetyl = moiety_modeling.Moiety(‘acetyl’, {‘13C’: 2}, isotopeStates={‘13C’: [0, 1, 2]},  nickname= ‘a’)  
uracil = moiety_modeling.Moiety(‘uracil’, {‘13C’: 4}, isotopeStates={‘13C’: [1, 2, 4]},  nickname= ‘u’) 
ribose = moiety_modeling.Moiety(‘ribose’, {‘13C’: 5}, isotopeStates={‘13C’: [0, 3, 5]},  nickname= ‘r’) 
Relationship relationship = moiety_modeling.Relationship(glucose, ‘13C0’, acetyl, ‘13C2’, ‘*’, 2) 
Molecule UDP-GlcNAc = moiety_modeling.Molecule(‘UDP-GlcNAc’, [glucose, uracil, acetyl, ribose]) 
Model model1 = moiety_modeling.Model(‘model1’, [glucose, uracil, acetyl, ribose], [UDP_GlcNAc], [relationship]) 
Dataset dataset = moiety_modeling.Dataset(‘12h’, ‘UDP_GlcNAc’: [{‘labelingIsotopes’:’13C_0’, ‘height’: 0.0175, 
‘heightSE’: 0 }, {‘labelingIsotopes’:’13C_1’, ‘height’: 0.0075, ‘heightSE’: 0 }, …] ) 
 
The moiety_modeling command-line interface. 
 
Usage: 
        moiety_modeling –h | --help 
        moiety_modeling --version 
        moiety_modeling modeling [--combinedData=<combined_jsonfile>] [--models=<models_jsonfile>] [--
datasets=<datasets_jsonfile>] [--optimizations=<optimizations_jsonfile>] [--working=<working_dir>] [--
repetition=<optim_count>] [--split] [--force] [--multiprocess] [--energyFunction=<function>] [--printOptimizationScripts] 
        moiety_modeling analyze optimization --a <optimzationPaths_txtfile> [--working=<working_dir] 
       moiety_modeling analyze optimization --s <optimzationResults_jsonfile> [--working=<working_dir] 
        moiety_modeling analyze rank <analysisPaths_txtfile> [--working=<working_dir>] [--rankCriteria=<rankCriteria>] 
        moiety_modeling analyze table <rankPaths_txtfile> [--working=<working_dir>] 
        moiety_modeling plot moiety <analysisResults_jsonfile> [--working=<working_dir>] 
        moiety_modeling plot isotopologue <analysisResults_jsonfile> [--working=<working_dir>] 
Options: 
        -h, --help                                                            Show this screen. 
        --version                                                            Show version. 
        -combinedData                                                 JSON description file of the combined data (eg: models, datasets,  
optimization settings) 
        --models=<models_jsonfile>                             JSON description file of the moiety models. 
        --datasets=<datasets_jsonfile>                         JSON description file of the datasets. 
        --optimizaitons=<optimizaitons_jsonfile>          JSON description file of the optimization setting. 
        --working=<working_dir>                                   Alternative path to save the results. 
        --repetition=<optim_count>                               The number of optimization repetitions to perform [default: 100]. 
        --split                                                                 To split the datasets or not. 
        --force                                                               To force optimization process if error occurs. 
        --mulitprocess                                                   To perform with multiprocessing or not. 
        --printOptimizationScripts                                  To print the optimization script or not. 
        --a                                                                      To analyze a bunch of optimization results together with the path 
file. 
        --s                                                                      To analyze a single moiety model optimization results. 
        --energyFunction=<function>                            The energy function for optimization [default: logDifference]. 
        --optimzationSetting=<optimizationSetting>     The optimization setting of the moiety modeling optimization. 
        --rankCriteria=<rankCriteria>                            The criteria for model ranking [default: AIC] 




Table 4.4. Common patters for using the moiety_modeling as a command-line tool 








Analyze the optimization 
results 
% python3 –m moiety_modeling analyze optimizations --a 
optimizationPaths.txt 
plot 
Plot the distribution of 
calculated moiety 
modeling parameters. 
% python3 –m moiety_modeling plot moiety 
analysisResults.json 
 
Table 4.5. Common patterns for using ‘SAGA’ module as a library. 
Usage Example 
SAGA 
saga = SAGA.SAGA(stepNumber=100, temperature=10, startTemperature=0.5, 
alpha=1, energyfunction=targertedEnergyFunction) 
saga.addElmentDescriptions(SAGA.ElementDecription(low=0, high=1)) 
Population population = saga.optimize() 
Guess bestGuess = population.bestGuess 
 
4.3.2 Dataset and model 
We used the timecourse (34h, 48h, and 72h) of 13C isotopologue data for UDP-
GlcNAc generated from [U-13C]-glucose in human prostate cancer LnCaP-LN3 cells to 
evaluate the robustness of the moiety modeling framework. An expert-derived moiety 
model of UDP-GlcNAc (6_G1R1A1U3) was created based on known human biochemical 
pathways (Figure 4.1A) and corroborated by NMR data. Also, 40 hypothetical moiety 
models of the isotopic flow into UDP-GlcNAc were crafted as simple perturbations of the 
original expert-derived model. These perturbations include the inclusion of different and/or 
additional moiety states and non-default moiety state relationships (e.g. g6 = r5).  For 
example, model 7_G2R1A1U3_g5 includes an extra 13C5 g5 glucose moiety state for a 
total of 7 independent model parameters, 2 for glucose, 1 for ribose, 1 for acetyl, and 3 for 
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uracil. We tested whether the expert-derived moiety model could be selected from all the 
other models.  
4.3.3 Model optimization and selection 
The incorporation of 13C from [U-13C]-glucose into UDP-GlcNAc leads to a total 
of 17 isotopologues plus one due to 13C natural abundance from carbon dioxide (I0, …, I17). 
We applied the moiety modeling framework to the observed UDP-GlcNAc isotopologue 
data with each built model to test whether the expert-derived moiety model could be 
selected above the other models. We used the SAGA optimization method with a log 
difference objective function (see Table 4.1). The optimization was repeated 100 times for 
each model. These analyses were performed on a desktop computer with i7-6850K CPU 
(6 core with HT), 64GB RAM and 512GB SSD. On this hardware, the analyses for all 40 
models took roughly 3 hours of total execution time. The results are list in the Table 4.6. 
From these results, we can see that the expert-derived moiety model can be selected 
successfully among all the moiety models using the AICc (see Table 4.2), which 
demonstrates the robustness of the moiety modeling framework.  Model selection criteria 
like the AICc help to address model overfitting; however, the use of a log difference 
objective function with multiple time points of data in the form of separate sets of observed 
isotopologues makes the model selection very robust against most of the model 
overfitting[68]. We also compared the optimization results generated by the moiety-
modeling package to results generated by GAIMS (see Supplementary Table 4.1 & 4.2, 
Supplementary Figure 4.1). For this comparison, an absolute difference objective function 
was used with the moiety-modeling package to match the objective function available in 
the GAIMS software.  Also, there are some small differences in the implementation of 
91 
 
optimization method between the two software packages. The SAGA-optimize package 
implements a true simulated annealing, while GAIMS implements a modified annealing 
with steepest decent qualities. Also, both optimization methods are stochastic as 
demonstrated by replicate moiety-modeling analyses shown in Supplementary Table 4.3. 
Therefore, the results are not identical; however, they are reasonably comparable.  But 
neither method is able to select the expert-derived model with an AICc model selection 
method, due to issues of overfitting with the absolute difference objective function. 
Table 4.6. Model selection results of UDP-GlcNAc isotopologue data 
Modela Estimator (AICc) 











































Optimization settings: method = ’SAGA’, SAGA_parameters = {‘stepNumber’: 100000, ‘temperatureStepSize’: 100, 
‘alpha’: 1, ‘crossoverRate’: 0.05, ‘mutationRate’: 3, ‘populationSize’: 20, ‘startTemperature’: 0.5}, repetition=100, 
split, objective function=log difference. 
aThe first number in the model name is the total number of free model parameters followed by the number of free 
parameters for each moiety and perturbations from the expert-derived model. 
 
4.3.4 Generation of simulated single-tracer and multi-tracer datasets 
In addition, we generated simulated single tracer and multi-tracer datasets to test, 
compare, and evaluate multi-tracer optimization functionality. First, we created a set of 
rounded moiety state values for the single-tracer expert derived model roughly based on 
the optimized model state values derived from the experimental UDP-GlcNAc 48h dataset 
(Table 4.7).  
Table 4.7. Single-tracer 13C moiety states and values for UDP-GlcNAc biosynthesis 
Moiety states Moiety value Moiety states Moiety value 
glucose[13C_0] 0.1 ribose[13C_5] 0.9 
glucose[13C_6] 0.9 uracil[13C_0] 0.2 
acetyl[13C_0] 0.7 uracil[13C_1] 0.2 
acetyl[13C_2] 0.3 uracil[13C_2] 0.5 




We then used 13C and 18O labeled glucose (13C6H1218O6) as a hypothetical isotope 
labeling source for UDP-GlcNAc biosynthesis. Following the expert derived model and 
with the aid of atom-mapping information of relevant human biochemical reactions from 
MetaCyc[78], we traced the incorporation of oxygen and carbon atoms from glucose to 
each moiety to derived a multi-tracer model. For glucose, acetyl and ribose, oxygen atoms 
incorporated into the moiety with their directly bonded carbon atom. However, during the 
biosynthesis of uracil, some 18O-13C bonds are sometimes broken, creating a more varied 
set of moiety states. Next, we derived rounded multi-tracer moiety state values that are 
equivalent to the rounded single-tracer values (Table 4.8). 
Table 4.8. Multi-tracer 13C/18O moiety states and values for UDP-GlcNAc biosynthesis 
Moiety states Moiety value Moiety states Moiety value 
glucose[13C_0.18O_0] 0.1 uracil[13C_0.18O_0] 0.2 
glucose[13C_6.18O_5] 0.9 uracil[13C_1.18O_0] 0.2 
acetyl[13C_0.18O_0] 0.7 uracil[13C_2.18O_0] 0.25 
acetyl[13C_2.18O_1] 0.3 uracil[13C_2.18O_1] 0.25 
ribose[13C_0.18O_0] 0.1 uracil[13C_3.18O_0] 0.05 
ribose[13C_5.18O_4] 0.9 uracil[13C_3.18O_1] 0.05 
 
Next, we generated the base single-tracer and multi-tracer simulated datasets by 
calculating the set of relative isotopologue intensity values using Equation 1 with the 
respective moiety state values.  Finally, we created simulated datasets with added normally 
distributed error that is subsequently thresholded to zero based on a minimum hypothetical 
detection limit (0.005) and then renormalized to a sum of 1.  We generated three sets of 
100 simulated datasets for both single and multi-tracer models by adding error from a 
normal distribution with increasing standard deviations of 0.001, 0.01 and 0.1. We then 
estimated the effects of error propagation by calculating the average sum of isotopologues 
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across 100 simulated datasets after error addition and thresholding, but before 
renormalization (Table 4.9). 
Table 4.9. Multi-tracer 13C/18O moiety states and values for UDP-GlcNAc biosynthesis 
σ of Added Error 
Average Sum of Isotopologues 
Single-tracer Multi-tracer 
0.1 1.50 9.97 
0.01 1.02 1.73 
0.001 0.99 0.98 
 
Based on this calculation, the single-tracer datasets and the multi-tracer datasets 
have comparable levels of propagated error when normal error with a 0.001σ is added.  
However, this quickly deviates with larger amounts of additive error as shown by single-
tracer datasets with a 0.1σ added normal error having slightly less propagated error than 
the multi-tracer datasets with a 0.01σ added normal error.  The multi-tracer datasets with a 
σ=0.1 added normal error are practically useless due to the level of propagated error being 
roughly nine (i.e. 9.97 - 1.00 = 8.97 ≈ 9) times the original signal on average.  Using 
histograms of simulated intensities for the largest respective isotopologue in both the 
single-tracer and multi-tracer simulated datasets, Figure 4.8 illustrates these error 
propagation effects due to thresholding and renormalization.  It is clear from this figure the 





Figure 4.8. Histograms of simulated intensities for the largest representative isotopologue. 
 
4.3.5 Model optimization of simulated multi-tracer and single-tracer datasets and 
comparison of results 
For each simulated dataset consisting of a single time point, the respective model 
was optimized 100 times (i.e. in 100 separate repetitions), each using 5000 steps of SAGA 
with an absolute objective function.  This generated 10,000 separate optimizations for each 
set of simulated datasets at a given added level of error.  Using histograms, Figure 4.9 
visualizes the distribution for the acetyl and uracil moiety state values for the multi-tracer 
dataset with 0.01σ added normal error and for the single-tracer datasets with σ=0.1 and 
σ=0.01 added normal error.  The full set of histograms are in Supplementary Figure 4.2 for 
the multi-tracer results and Supplementary Figure 4.3 for the single tracer results.  When 
comparing multi-tracer and single-tracer experiments with equivalent added normal error 
(σ=0.01), the propagated error leads to wider variances in the multi-tracer moiety state 
values and some additional skewness of their distributions. However, some of the single-
tracer moiety state value distributions are bimodal.  When comparing multi-tracer and 
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single-tracer experiments with comparable propagated error levels, the multimodality in 
the single-tracer distributions become very pronounced, especially in the acetyl moiety 
states.       
 
Figure 4.9. Histograms of the acetyl and uracil optimized moiety state values derived from 
simulated datasets. 
4.4 Discussion 
4.4.1 Advantage of JSONized representation for MS isotopologue data and analysis 
results 
JavaScript object notation (JSON)[138] is an open-standard file format using 
human-readable text to collect data in pair-value and array structures, widely used by 
different programming language. Complex Python objects, like ‘Moiety’ and ‘Molecule’ 
objects mentioned above, can be serialized to JSON format with the jsonpickle Python 
library. The moiety model and dataset constructed with moiety_modeling package as well 
as optimization parameters are the input files for the moiety modeling, all of which are 
saved in JSON format using jsonpickle (see Supplementary Data 4.1, 4.2 and 4.5). The use 
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of JSON format makes the moiety modeling framework easily accessible to other 
programming languages and naturally extendible. In addition, the optimization and 
analysis results are also stored in a JSON file (see Supplementary Data 4.3 & 4.4).  
4.4.2 Advantages and limitations of the SAGA-optimize and moiety-modeling 
packages 
The SAGA-optimize package provides certain advantages to the model 
optimization versus the other optimization methods from scipy and even a similar 
implementation in GAIMS.  The level and steepness of optimization can be precisely tuned 
with the specification of the annealing length and schedule. Also, this novel 
implementation of a combined simulated annealing and genetic algorithm incorporates the 
annealing processing directly into the mutation step itself, attenuating the level of mutation 
as the annealing temperature drops.  The moiety-modeling package provides a range of 
objective functions and can split each independent set of isotopologues into individual 
moiety model optimizations, which neither the GAIMS nor MAIMS packages can do.  
Moreover, both the SAGA-optimize and moiety-modeling packages have multiprocessing 
facilities that enable an efficient utilization of all CPU cores. As demonstrated in the Table 
4.6 results, the combination of advantages allows the moiety-modeling package to optimize 
and accurately select the expert-derived model in roughly one tenth of the execution time 
of the original GAIMS package, i.e. with 100,000 steps of optimization in moiety-modeling 
versus 1,000,000 steps in GAIMS. Also, both the SAGA-optimize and moiety-modeling 
packages contain over 2200 lines of code implemented in major version 3 of the Python 
language with a fully object-oriented design and Pythonic style. Every module, class, 
method, and function have documentation strings (docstrings) written in the 
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reStructuredText markup language.  Variables, data members, methods, functions, and 
classes have descriptive names as demonstrated in Figures 4.4, 4.5, and 4.6.  
Documentation is automatically generated using the Sphinx Python Document Generator 
and made available on ReadTheDocs.  This documentation includes a user guide, 
installation instructions, tutorial, and application programming interface (API) reference. 
Both packages are available on GitHub, utilize Travis CI for continuous integration, and 
are distributed via the Python Package Index. Code coverage from unit testing is above 65% 
for moiety-modeling and above 73% for SAGA-optimize. These packages enable 
researchers to perform moiety model isotopologue deconvolution using JSON 
representations of moiety models, datasets, and optimization method selection and settings 
provided by the user. At this time, the moiety-modeling package has no facilities for 
automatic moiety model generation.  
4.4.3 Difficulty in generating simulated datasets and comparing multi-tracer to single-
tracer moiety modeling results 
The generation of realistic simulated biophysical datasets is always a non-trivial 
task[138].  Even the addition of normal additive error can create non-intuitive propagation 
of error, especially through inverse problems[139]. This is illustrated in Table 4.8 and 
Figure 4.8, where thresholding creates a positive bias in accumulated error and the 
renormalization creates a proportional-like error component from this positive 
accumulated error. The thresholding is required to keep the simulated data within the 
physical boundaries of the analytical detection, i.e. all non-negative values.  The 
renormalization keeps the simulated data within mathematical boundaries, i.e. the sum of 
the isotopologue values is equal to 1. Neither step can be avoided with the inclusion of 
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normal additive error. This created error propagation problem is quite dramatic for the 
simulated multi-tracer datasets, because there are 324 possible isotopologues in the multi-
tracer datasets as compared to only 18 isotopologues in the single-tracer datasets. This 
problem simply increases in magnitude with the number of isotopologues present in a 
dataset. With a σ=0.1 added normal error, the isotopologue intensity information is 
effectively lost for the multi-tracer datasets (see Figure 4.8) and these datasets become 
effectively unusable (see Supplementary Figure 4.2). However, the lower additive error 
datasets are usable and illustrate the power of multi-tracer datasets to reduce multimodality 
in optimized moiety state values as compared to the single-tracer datasets.  
4.5 Conclusions 
Here, we present a moiety modeling framework for the deconvolution of metabolite 
isotopologue profiles using moiety models along with the analysis and selection of the best 
moiety model(s) based on the experimental data. This framework can analyze datasets 
involving single and multiple isotope tracers as demonstrated on simulated datasets for 
multiple tracer models and both simulated and experimental datasets on single tracer 
models. With a 13C-labeled UDP-GlcNAc isotopologue dataset, we further demonstrate the 
robust performance of the moiety modeling framework for model selection on real 
experimental datasets. The selection of correct moiety models is required for generating 
deconvolution results that can be accurately interpreted in terms of relative metabolic flux. 
Furthermore, the JSON formats of moiety model, isotopologue data, and optimization 
results facilitate the inclusion of these tools in data analysis pipelines. Future work will 
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explore the data quality requirements of model selection and validation of multiple isotope 







CHAPTER 5. ROBUST MOIETY MODEL SELECTION USING MASS SPECTROMETRY 
MEASURED ISOTOPOLOGUES 
5.1 Introduction 
While the first observations of metabolic alterations in cancer were made about a 
century ago[140], metabolomics is a relatively new field of ‘omics’ technology aiming to 
systematically characterize metabolites being created and/or utilized in cells, tissues, 
organisms, and ecosystems[141]. This combined consumption and biosynthesis of 
metabolites can be represented as flux through specific metabolic paths within cellular 
metabolism, reflecting specific physiological and pathological states in biomedically useful 
detail and in ways that are distinct and often more sensitive than other omics methods. It is 
increasingly recognized that metabolomics biomarkers have great utility in characterizing 
and monitoring diseases with significant metabolic reprogramming like cancer[127]. 
Therefore, better regulatory understanding of specific metabolic flux phenotypes of 
metabolic diseases will aid in developing new therapeutic strategies.  
Stable isotope resolved metabolomics (SIRM) experiments utilize stable isotopes 
from a labeling source to isotopically enrich detected metabolite analytical features, 
providing more complex but data-rich metabolomics datasets for metabolic flux analysis. 
Advances in mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR) 
greatly contribute to the generation of high-quality SIRM datasets[48]. However, 
computational methods are required to gain biologically meaningful interpretation from 
such complex datasets, especially in terms of metabolic flux through specific metabolic 
paths in cellular metabolism. Most current metabolic flux analysis methods heavily depend 
on a predetermined metabolic network and are mostly focused on the analysis of 13C tracer 
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experiments[53, 56, 65, 142]. However, large numbers of ‘unknown’ metabolites in the 
metabolomics datasets strongly indicate that current metabolic network are far from 
complete, especially for secondary metabolism and central metabolism of non-model 
organisms[129, 143, 144]. Without an accurate and reasonably-defined metabolic network, 
it is challenging to conduct meaningful metabolic flux analyses.  Even worse, assuming a 
metabolic model is accurate compromises the scientific rigor of the metabolic modeling 
and can lead to misinterpretation of results[139].  
Our newly developed moiety deconvolution package called moiety_modeling is a 
novel method for analyzing time series SIRM MS isotopologue profiles that can involve 
single or multiple isotope tracers[69]. This package integrates facilities for moiety (i.e. 
biochemical functional group) model and data representation, model (parameter) 
optimization, analysis of optimization results, and model selection under a single moiety 
modeling framework. A typical data analysis workflow for this moiety modeling 
framework is shown in Figure 5.1. Moiety modeling deconvolutes isotopologue intensity 
data of a metabolite into pseudo-isotopomers based on a given moiety description of the 
metabolite.  Moiety modeling is an early step in certain metabolic flux analysis approaches 
that can allow the comparison of different moiety models for model selection. First, 
plausible and hypothetical moiety models of an interesting metabolite are provided by a 
user based on a relevant metabolic network. After the optimization of each moiety model 
during isotopologue deconvolution, the optimal model can be selected based on the 
optimized results of model parameters, which can be directly used for downstream 





Figure 5.1. Workflow for Moiety Modeling. 
 
In this chapter, we use this moiety modeling framework to investigate the effects of 
the optimization method, optimizing degree, objective function and selection criterion on 
model selection to identify modeling criteria that promote robust model selection. To our 
knowledge, this is the first attempt to investigate how all of these factors can affect model 
selection in metabolic modeling.  
5.2 Materials and Methods 
5.2.1 UDP-GlcNAc time course MS isotopologue datasets 
Two UDP-GlcNAc time course MS isotopologue datasets were used to test the 
robustness of model selection mechanism. The first is a direct infusion Fourier transform 
MS (FTMS) UDPGlcNAc 13C isotopologue dataset derived from LnCaP-LN3 human 
prostate cancer cells with [U-13C]-glucose as isotope labeling source and collected on an 
Advion Nanomate nanoelectrospray inline connected to a Thermo 7T LTQ Fourier 
transform ion cyclotron resonance MS (FT-ICR-MS). This dataset includes 3 time points: 
34h, 48h, and 72h[68]. The second is a liquid chromatography-MS (LC-MS) UDP-GlcNAc 
13C isotopologue dataset derived from human umbilical vein endothelial cells with [U-13C]-
glucose as the isotope labeling source and collected on a ThermoFisher Dionex UltiMate 
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3000 LC System in-line connected to a ThermoFisher Q-Exactive Orbitrap MS. This 
dataset has 5 time points: 0h, 6h, 12h, 24h and 36h[128].  
5.2.2 Objective functions 
We used four distinct forms of the objective function (Table 5.1) that compares the 
observed isotopologues and corresponding calculated isotopologues derived from model 
parameters obtained from model optimization.  The first is a summation of absolute 
differences between observed and calculated isotopologues, which is generally expected to 
work well with data where the dominant type of error is additive.  The second is a 
summation of the absolute differences between the log of observed and calculated 
isotopologues, which is generally expected to work well with data where the dominant type 
of error is proportional.  The third is a summation of square of differences between 
observed and calculated isotopologues. The fourth one tries to mimic the effect of model 
selection criteria. 
Table 5.1. Objective functions. 
Objective function Equation 
Absolute difference Σ|In,obs – In,calc| 
Absolute difference of logs Σ|log(In,obs) – log(In,calc)| 
Square difference Σ(In,obs – In,calc)2 
Difference of AIC 2k + nln(RSS/n) 
k is the number of parameters. 
n is the number of data points. 




5.2.3 Optimization methods 
From a mathematics perspective, model optimization is actually a non-linear 
inverse problem. Several different optimization methods were used to solve this problem, 
including the SAGA-optimize method[68], and three other optimization methods 
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(‘TNC’[130], ‘SLSQP’[131], and ‘L-BFGS-B’[132]) available in the scipy.optimize 
Python module. The SAGA-optimize is a combination of simulated annealing (SA) and 
genetic algorithm (GA) that gains advantages of both SA and GA, making it able to produce 
better quality results in small amount of time. The ‘TNC’ method is designed for 
optimizing non-linear functions with large numbers of independent variables[130]. The 
SLSQP method uses Sequential Least Squares Programming, which is an iterative method 
for constrained nonlinear optimization[131]. ‘L-BFGS-B’ is a limited-memory algorithm 
for solving large nonlinear optimization problems subject to simple bounds on the 
variables[132]. 
5.2.4 Model Selection Estimators 
We used three different quality estimators (Table 5.2) in model selection: the 
Akaike Information Criterion (AIC)[133], the sample size corrected Akaike Information 
Criterion (AICc)[136], and the Bayesian Information Criterion (BIC)[134]. The Akaike 
information criterion (AIC) is biased to select models with more parameters when the 
sample size is small, which can lead to overfitting[133]. The sample size corrected AIC 
(AICc) was developed to handle this bias and prevent overfitting[136]. The Bayesian 
information criterion (BIC) is another criterion commonly used in model selection[134]. 
Table 5.2. Model selection estimators. 
Selection Criterion Equation 
Akaike Information Criterion (AIC) 2k + nln(RSS/n) 
Sample size corrected AIC (AICc) AIC + (2𝑘2 + 2𝑘)/(𝑛 − 𝑘 − 1) 
Bayesian Information Criterion (BIC) nln(RSS/n) +  kln(n) 
k is the number of parameters. 
n is the number of data points. 







5.3.1 UDP-GlcNAc moiety model construction. 
UDP-GlcNAc can be divided into four distinct moieties: glucose, ribose, acetyl, 
and uracil, in which isotopes incorporate through a metabolic network from an isotope 
labeling source.  The expected  (expert-derived) moiety model of 13C isotope incorporation 
from 13C-labeled glucose to UDP-GlcNAc (see Figure 5.2 B) is built based on well-studied 
human central metabolism pathways that converge in UDP-GlcNAc biosynthesis, which is 
corroborated with NMR data[68]. This expert-derived model is labeled as 6_G1R1A1U3, 
representing six optimizable parameters, one for the glucose moiety (G1), one for the ribose 
moiety (R1), one for the acetyl moiety (A1), and 3 for the uracil moiety (U3), for each 
moiety state equation representing the fractional 13C incorporation for each moiety. For 
example, the g6 state represents the incorporation of 13C6 into the glucose moiety, whereas 
the g0 state represents no incorporation of 13C.  Since both g0 and g6 must sum to 1, there 
is only one parameter that needs to be optimized for this moiety state equation. The set of 
isotopologue intensity equations are derived using the moiety model parameters and 
Equation 1, as illustrated for the expert-derived model in Figure 5.2 B. Figure 5.2 C shows 
an alternative hypothetical moiety model 7_G0R3A1U3_g3R2R3_g6r5_r4 along with the 




𝐼𝑥,𝑐𝑎𝑙𝑐 = ∑ 𝑖𝑐𝑎
𝑖𝑐𝑎∈𝐼𝐶𝑥
  ;  𝐼𝐶𝑥 = {𝑖𝑐𝑣|𝑖𝑠𝑜𝑡𝑜𝑝𝑒_𝑐𝑜𝑛𝑡𝑒𝑛𝑡(𝑖𝑐𝑣) = 𝑥}  ; 𝑖𝑐𝑣 = ∏ 𝑚𝑜𝑖𝑒𝑡𝑦_𝑠𝑡𝑎𝑡𝑒𝑗,𝑣𝑗
𝑗
          (1) 
We also manually crafted 40 hypothetical moiety models to capture isotope flow 
from [U-13C]-glucose into each moiety. This set of models provides a mechanism for 
testing how robustly the expert-derived model can be selected from all the other models. 
 
Figure 5.2. Example complex metabolite UDP-GlcNAc and associated moiety models.  
A) Major human metabolic pathways from glucose to the four moieties of UDP-GlcNAc. 
B) The expert-derived moiety model based on known human central metabolism pathways 
with corroborating NMR data. C) An alternative hypothetical moiety model with simple 
perturbations of the original expert-derived model. 
 
5.3.2 A simple comparison of two moiety models 
Model optimization aims to minimize an objective function that compares 
calculated isotopologues based on moiety state parameters from the model to the directly 
observed, experimentally-derived isotopologues. Figure 5.3 A shows the comparison of 
optimized model parameters between the expert-derived moiety model (6_G1R1A1U3) 
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and the hypothetical moiety model (7_G0R3A1U3_g3r2r3_r4) for three time points of 
isotopologue intensity data, i.e. three sets of isotopologue intensities. In these model 
optimizations, the SAGA-optimize method and absolute difference objective function were 
used and DS0, DS1, and DS2 correspond to the 34h, 48h, and 72h time points in the FT-
ICR-MS UDP-GlcNAc dataset. We can easily tell that the relative intensity of the 
corresponding model parameters between these two models are quite different, suggesting 
that the moiety-specific 13C isotopic incorporation derived from the same MS isotopologue 
profile varies from one model to another. Furthermore, experiment-derived and model 
parameter-calculated isotopologue profiles are shown in Figure 5.3 B, illustrating how 





















































































































































































































































































































































































































































Figure 5.3. Optimized results for 6_G1R1A1U3 and 7_G0R3A1U3_g3r2r3_r4 models.  
Each model optimization was conducted 100 times. A) Comparison of mean of optimized 
model parameters with standard deviation. B-D) Reconstruction of the isotopologue 
distribution of UDP-GlcNAc from model parameters. Observed isotopologue data was 
compared with the mean of calculated isotoplogue data with standard deviation from the 
optimized parameters for each model. 
 
5.3.3 Effects of optimization method on model selection 
The first question we were interested in was whether the optimization method could 
affect the model selection results. As in the previous analysis, we used 3 time points from 
the FT-ICR-MS dataset, the AICc criterion, and an absolute difference objective function 
in the initial trial. The optimization for each model was conducted 100 times, and we used 
the average of the 100 optimization results in the analysis (see Table 5.3). Most 
optimization methods can select the expert-derived model except for ‘SLSQP’. What 
interested us most was that the ‘SLSQP’ method failed in model selection with the lowest 
loss value (value returned from objective function) and is generally considered to be the 





















































































































We repeated the experiment with the ‘SLSQP’ method 10 times and found that 
model selection fails when the loss value approaches 0.3, suggesting strong instability of 
model selection at a critical point. Model optimization aims to minimize the objective 
function, which is actually a non-linear inverse problem, and one inherited issue in solving 
a non-linear inverse problem is overfitting (i.e. fitting to error in the data). Therefore, we 
developed the hypothesis that over-optimization of model parameters can lead to failure in 
model selection. 
Table 5.3. Comparison of optimization methods in model selection. 
Optimization method Loss value AICc Selected model 
SAGA 0.469 -401.760 Expert-derived model 
SLSQP 0.320 -408.341 7_G2R1A1U3_g5 
L-BFGS-B 0.763 -342.164 Expert-derived model 
TNC 0.870 -327.344 Expert-derived model 
Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference. 
 
5.3.4 Over-optimization leads to failure in model selection. 
To test the above hypothesis, we first tried to increase the stop criterion of ‘SLSQP’ 
method to control over-optimization. The results are shown in Table 5.4. When 
optimization stops earlier, the expert-derived model can be selected, which supports our 
hypothesis.  
The SAGA-optimize method is more flexible in controlling the degree of 
optimization simply by adjusting the number of optimization steps. The more steps, the 
lower the average loss value reached by the optimization. Next, we performed a set of 
experiments using the SAGA-optimize method with increasing number of optimization 
steps to further validate the hypothesis. The results are summarized in the Table 5.5. We 
can see that the loss value decreases as optimization step increases. When the loss value 
reaches a certain critical point, the expert-derived model cannot be selected, further 
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supporting the hypothesis that over-optimization can lead to failure in model selection.  
Furthermore, the selected model can change with increasing degrees of over-optimization. 
Based on the above results, we conclude that it is not the optimization method but the 
degree of optimization that affects model selection, which is explained by overfitting to 
error in the data when solving a non-linear inverse problem. When optimization reaches a 
certain critical point, successful model selection cannot be guaranteed. Therefore, proper 
control of the degree of optimization is of great importance in model selection. 
Table 5.4. Over optimization experiments with ‘SLSQP’ method. 
Optimization 
method 
Loss value AICc Selected model 
Stop 
criterion 
SLSQP 0.320 -408.341 7_G2R1A1U3_g5 ‘ftol': 1e-06 
SLSQP 0.514 -393.934 Expert-derived model ‘ftol': 1e-05 
Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference. 
 
Table 5.5. Over optimization experiments with SAGA-optimize method. 
Optimization steps Loss value AICc Selected model 
500 2.070 -219.488 Expert-derived model 
1000 1.754 -235.728 Expert-derived model 
2000 1.377 -260.654 Expert-derived model 
5000 0.941 -305.651 Expert-derived model 
10000 0.664 -375.192 Expert-derived model 
25000 0.469 -401.760 Expert-derived model 
50000 0.408 -414.737 Expert-derived model 
75000 0.328 -418.228 7_G2R1A1U3_g5 
100000 0.316 -424.924 7_G1R2A1U3_r4 
Dataset: FT-ICR-MS (combined); Selection criterion: AICc; Objective function: Absolute difference. 
 
5.3.5 Effects of selection criterion on model selection 
Next, we investigated whether selection criterion could affect model selection. We 
compared the model selection results generated by SAGA-optimize with different model 
selection criteria (see Table 5.6). From these results, we can see that the rank of top models 
is quite consistent across different selection criteria, suggesting that these model selection 
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criteria have little effect on robust model selection, at least under this model selection 
context. Since our previous experiments used AICc as the selection criterion, we will stick 
with AICc in the following experiments. 
Table 5.6. Comparison of mode rank based on different model selection criteria. 
Models AICc rank AIC rank BIC rank 
Expert-derived model -401.7597 1 -421.3026 1 -385.5009 1 
7_G1R1A2U3 -384.3075 2 -413.1825 2 -371.4139 2 
7_G2R1A1U3_g5 -381.2868 3 -410.1618 3 -368.3932 3 
7_G1R2A1U3_r3 -379.2657 4 -408.1407 4 -366.3720 4 
7_G1R2A1U3_r4 -378.8969 5 -407.7719 5 -366.0033 5 
7_G2R1A1U3_g4 -375.9538 6 -404.8288 6 -363.0601 6 
6_G1R1A1U3_g5 -374.9694 7 -394.5122 10 -358.7105 8 
6_G1R1A1U3_r4 -374.1820 8 -393.7249 11 -357.9231 9 
7_G1R1A1U4 -373.4563 9 -402.3313 7 -360.5626 7 
6_G1R1A1U3_u4 -370.0716 10 -389.6145 13 -353.8127 11 
7_G2R1A1U3_g1 -367.8353 11 -396.7103 8 -354.9416 10 
7_G2R1A1U3_g2 -360.1668 12 -389.0418 14 -347.2732 13 
7_G1R1A1U3C1 -360.0296 13 -388.9046 15 -347.1360 14 
7_G1R2A1U3_r1 -354.8814 14 -383.7564 16 -341.9878 16 
8_G1R2A2U3_r3 -354.4480 15 -395.8273 9 -348.0917 12 
8_G2R1A2U3_g4 -351.9886 16 -393.3679 12 -345.6323 15 
6_G0R2A1U3_g3r2r3_g6r5 -345.1277 17 -364.6706 21 -328.8689 17 
8_G2R1A2U3_g1 -334.2882 18 -375.6675 17 -327.9319 18 
7_G2R1A1U3_g3 -332.9148 19 -361.7898 22 -320.0211 19 
7_G1R2A1U3_r2 -332.3262 20 -361.2012 23 -319.4326 21 
8_G1R2A2U3_r1 -325.9344 21 -367.3137 18 -319.5781 20 
8_G1R1A2U3C1 -324.5196 22 -365.8989 19 -318.1633 22 
8_G2R1A2U3_g5 -324.5004 23 -365.8797 20 -318.1441 23 
7_G0R2A2U3_g3r2r3_g6r5 -324.0749 24 -352.9499 26 -311.1813 25 
7_G1R2A1U3_g3r2r3 -324.0721 25 -352.9471 27 -311.1784 26 
8_G2R1A2U3_g2 -318.5771 26 -359.9564 24 -312.2208 24 
6_G1R1A1U3_a1 -318.2498 27 -337.7927 31 -301.9910 28 
8_G1R2A2U3_r4 -317.3169 28 -358.6962 25 -310.9606 27 
8_G2R1A2U3_g3 -302.7897 29 -344.1690 28 -296.4334 29 
8_G1R2A2U3_g3r2r3_g6r5_g5 -297.7429 30 -339.1222 30 -291.3866 30 




5.3.6 Effects of selection criterion on model selection 
Considering that the dominant type of error existing in metabolomics datasets may 
vary from dataset to dataset, different forms of objective function may affect model 
optimization and then influence the results of model selection. Here, we test the effects of 
four objective functions in the context of model selection: absolute difference, absolute 
difference of logs, square difference, and difference of AIC. To speed up optimization, we 
first split the FT-ICR-MS dataset based on time point (34h, 48h, 72h) into separate model 
optimizations executed on their own CPU core, and then combine the optimization results 
for the model selection. This functionality is provided by the moiety_modeling package. 
We set a series of experiments for each objective function with SAGA-optimize method. 
The results are shown in Table 5.7 to Table 5.10. In comparing Table 5.7 to Table 5.5, the 
number of optimizations per time point provides roughly the same degree of optimization 
as three times the number of optimization steps used on a combined optimization.   
From these tables, we can see that optimization with the absolute difference of logs 
objective function is less likely to fail (> 250000 steps) in the model selection compared to 
the other three objective functions (10000 - 20000 steps). One interpretation from these 
8_G1R2A2U3_r2 -294.7900 32 -336.1693 33 -288.4337 32 
8_G1R2A2U3_g3r2r3 -292.7867 33 -334.1660 34 -286.4304 33 
9_G2R2A2U3_r2r3_g6r5_g3_g5 -281.8920 34 -340.0458 29 -286.3433 34 
7_G0R3A1U3_g3r2r3_g6r5_g5r4 -279.0349 35 -307.9099 37 -266.1412 36 
9_G2R2A2U3_r2r3_g4 -273.5807 36 -331.7345 35 -278.0320 35 
9_G2R2A2U3_r2r3_g5 -254.4087 37 -312.5625 36 -258.8599 37 
9_G2R2A2U3_r2r3_g3 -248.2277 38 -306.3815 38 -252.6789 38 
9_G2R2A2U3_r2r3_g2 -242.9984 39 -301.1522 39 -247.4497 39 
9_G2R2A2U3_r2r3_g1 -242.4110 40 -300.5648 40 -246.8623 40 
7_G0R3A1U3_g3r2r3_g6r5_r4 -226.7271 41 -255.6021 41 -213.8334 41 
Dataset: FT-ICR-MS (combined); Optimization method: SAGA-optimize (25000 steps); Objective function: Absolute difference. 
115 
 
results is that the FT-ICR-MS dataset is dominated by proportional error instead of additive 
error. However, the AICc produced with the absolute difference of logs is significantly 
higher (less negative) than that produced by the other objective functions. Therefore, this 
objective function may simply be hindering efficient optimization, especially if the dataset 
is dominated by an error structure that is not as compatible with this objective function. 
From this alternative viewpoint, additive error may actually dominate this dataset. We used 
a graphical method to visualize errors in both FT-ICR-MS and LC-MS datasets (Figure 5.4 
and 5.5). For the plots of FT-ICR-MS datasets, we used another dataset generated from the 
same procedure, which included two replicates at 0, 3h, 6h, 11h, 24h, 34h, and 48h time 
points. For two replicates with proportional error, a scatter plot of each replicate against 
the other will show an increasing spread of values with increasing signal, and the log-
transformed data will collapse into a line. Plot of two replicates with additive error can be 
viewed as uniformly deviated from the line of identity, but once log-transformed will show 
an increasing spread of values with decreasing signal. The original plots of raw data 
indicate existence of proportional error in both FT-ICR-MS and LC-MS datasets (Figure 
5.4 A and 5.5 A). However, the original plots of normalized data almost collapsed to a 
straight line (Figure 5.4 C and 5.5 C), suggesting that normalization somehow removes the 
proportional error in the raw data. In addition, from the log-transformed plots, we can see 
that additive error does not exist in the normalized FT-ICR-MS datasets (Figure 5.4 D), 
but does exist in the normalized LC-MS datasets (Figure 5.5 D). The replicate plots of all 
time points (Figure 5.6 & 5.7) show similar tendency with selected optimized datasets. 
Based on the above results, the absolute difference of logs objective function can hinder 
efficient optimization in FT-ICR-MS datasets. We also compared four objective functions 
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in the context of model selection with LC-MS datasets (Table 5.11-5.14). From these tables, 
we can see that model selection fails earlier with absolute difference of logs objective 
function compared to other objective functions, also suggesting that additive error may 
dominate in the normalized LC-MS datasets. Based on the above results, the objective 
function clearly affects model selection and the selection of certain objective functions for 
model optimization is able to increase resistance to failure in model selection caused by 
over-optimization; however, this is likely due to less efficient model optimization caused 
by the selection of an objective function not appropriate for the type of error in the data. 
Table 5.7. Model selection test with absolute difference objective function. 
Optimization steps Loss value AICc Selected model 
500 1.045 -293.540 Expert-derived model 
1000 0.819 -330.411 Expert-derived model 
2000 0.651 -361.038 Expert-derived model 
5000 0.459 -408.167 Expert-derived model 
10000 0.392 -422.516 Expert-derived model 
15000 0.359 -431.276 Expert-derived model 
20000 0.290 -434.468 7_G1R1A2U3 
25000 0.285 -436.909 7_G1R1A2U3 
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: absolute difference. 
 
Table 5.8. Model selection test with square difference objective function. 
Optimization steps Loss value AICc Selected model 
500 0.085 -298.516 Expert-derived model 
1000 0.047 -330.096 Expert-derived model 
2000 0.023 -367.279 Expert-derived model 
5000 0.011 -404.509 Expert-derived model 
10000 0.007 -425.695 Expert-derived model 
15000 0.005 -429.869 7_G2R1A1U3_g5 
20000 0.005 -435.348 7_G1R2A1U3_r4 






Table 5.9. Model selection test with absolute difference of logs objective function. 
Optimization steps Loss value AICc Selected model 
500 31.647 -221.501 Expert-derived model 
1000 29.628 -223.363 Expert-derived model 
2000 28.164 -224.330 Expert-derived model 
5000 27.096 -225.911 Expert-derived model 
10000 26.631 -227.499 Expert-derived model 
15000 26.469 -227.690 Expert-derived model 
20000 26.398 -227.780 Expert-derived model 
25000 26.271 -228.178 Expert-derived model 
50000 26.126 -228.892 Expert-derived model 
100000 25.949 -228.926 Expert-derived model 
150000 25.865 -229.926 Expert-derived model 
250000 25.777 -230.232 Expert-derived model 
Dataset: FT-ICR-MS (split); Selection criterion: AICc; Objective function: absolute difference of logs. 
 
Table 5.10. Model selection test with difference of AIC objective function. 
Optimization steps Loss value Selected model 
500 -345.559 Expert-derived model 
1000 -371.852 Expert-derived model 
2000 -398.570 Expert-derived model 
5000 -436.582 Expert-derived model 
10000 -458.064 7_G1R1A2U3 
15000 -467.960 7_G2R1A1U3_g5 













Figure 5.4. Error analysis in FT-ICR-MS datasets.  
A and B are plots of raw data. C and D are plots of renormalized data after natural 


















Figure 5.5. Error analysis in LC-MS datasets.  
A and B are plots of raw data. C and D are plots of renormalized data after natural 








Figure 5.6. Error analysis in FT-ICR-MS datasets. 
A and B are plots of raw data. C and D are plots of renormalized data after natural 








Figure 5.7. Error analysis in LC-MS datasets. 
A and B are plots of raw data. C and D are plots of renormalized data after natural 
abundance correction. All these plots contain all time points. 
 
Table 5.11. Model selection test with absolute difference objective function. 
Optimization steps Loss value AICc Selected model 
500 0.840 -344.734 Expert-derived model 
1000 0.682 -368.696 Expert-derived model 
2000 0.580 -386.000 Expert-derived model 
5000 0.492 -398.243 Expert-derived model 
10000 0.447 -402.611 Expert-derived model 
15000 0.430 -405.722 Expert-derived model 
25000 0.458 -407.414 6_G1R1A1U3 










Table 5.12. Model selection test with square difference objective function. 
Optimization steps Loss value AICc Selected model 
500 0.031 -348.250 Expert-derived model 
1000 0.021 -368.818 Expert-derived model 
2000 0.015 -387.196 Expert-derived model 
5000 0.011 -404.563 Expert-derived model 
10000 0.010 -411.177 Expert-derived model 
15000 0.010 -413.499 Expert-derived model 
25000 0.009 -415.498 Expert-derived model 
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: square difference. 
 
Table 5.13. Model selection test with absolute difference of logs objective function. 
Optimization steps Loss value AICc Selected model 
500 50.595 -315.616 Expert-derived model 
1000 47.213 -319.026 Expert-derived model 
2000 44.137 -323.619 Expert-derived model 
5000 40.811 -320.949 Expert-derived model 
10000 39.474 -328.551 Expert-derived model 
15000 57.856 -331.700 6_G1R1A1U3 
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: absolute difference of logs. 
 
Table 5.14. Model selection test with difference of AIC objective function. 
Optimization steps Loss value Selected model 
500 -365.957 Expert-derived model 
1000 -389.987 Expert-derived model 
2000 -409.322 Expert-derived model 
5000 -427.064 Expert-derived model 
10000 -435.618 Expert-derived model 
15000 -437.970 Expert-derived model 
25000 -439.533 Expert-derived model 
Dataset: LC-MS (split); Selection criterion: AICc; Objective function: difference of AIC. 
 
5.3.7 Effects of information quantity on model selection 
From the above experiments, we found that over-optimization is a primary cause 
for failure in model selection and this is affected by the objective function used. The next 
question is whether the quantity of information affects model selection. One basic approach 
is to utilize more datasets in order to overcome the effects of over-optimization. In the 
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following experiments, we repeated single model optimization 10 times in order to 
pragmatically finish these computational experiments. Every experiment was conducted 
10 times using the AICc criterion and the absolute difference objective function. We used 
the SAGA-optimize method to test where model selection starts to fail.  
First, we used decreasing number of time points of the LC-MS dataset to test 
whether data quantity affects model selection (Figure 5.8 A, Table 5.15). However, model 
selection failed with few optimization steps when all five time points were included and 
when only one time point was included, with the most robust model selection occurring 
with 3 time points. Initially, these results were not expected, until we realized that the 
relative isotopologue intensity of the 0 and 6h time points is concentrated within the 13C0 
isotopologue with zero 13C tracer. Thus, these datasets are less informative with respect to 
capturing the isotope flow from labeling source to each moiety in the metabolite. When the 
0 and 6h time points are removed, the selection results improved significantly. Likewise, 
when information-rich time points are removed, the model selection robustness decreases 
as well. Similar results were obtained when testing the FT-ICR-MS dataset (Figure 5.8 B). 
Taken together, the addition of information-rich data contributes to successful model 
selection while the addition of information-poor data detracts from successful model 
selection. 
To further test this concept, we investigated whether combining FT-ICR-MS (34h, 48h, 
72h) and LC-MS (12h, 24h, 36h) datasets can prevent failure in model selection (Figure 
5.8 C). From the comparison, we can see that combining information-rich FT-ICR-MS and 
LC-MS datasets is much more resistant to failure of model selection than just using the 
information-rich FT-ICR-MS or LC-MS dataset, strongly supporting our previous 
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conclusions that utilizing more information-rich datasets can prevent failure in model 
selection.  Similar results were obtained with absolute difference of logs objective function 
(Figure 5.9). These datasets were collected at different times, on very different mass 
spectrometry platforms.  One used chromatographic separation while the other utilized 
direct infusion.  However, the really surprising part is that the datasets were derived from 
different human cell cultures: LnCaP-LN3 human prostate cancer cells and human 








Figure 5.8. Comparison of the log optimization steps where model selection with different 
datasets begins to fail.  
A) Test with LC-MS datasets. LC-MS_1 to LC-MS_5 represent LC-MS datasets with 36h, 
24-36h, 12-36h, 6-36h and 0-36h. B) Test with FT-ICR-MS datasets. FT-ICR-MS_1 to FT-
ICR-MS_3 represent FT-ICR-MS datasets with 48h, 48-72h and 34-72h. C) Test with 
combination of LC-MS (12h, 24h, 36h) and FT-ICR-MS (34h, 48h, 72h) datasets. The 
median values are indicated in the plots. 
 




5 time points 
(0-36h) 
4 time points 
(6-36h) 
3 time points 
(12-36h) 
2 time points 
(24-36h) 
1 time point 
(36h) 
500 ED model ED model ED model ED model ED model 
1000 ED model ED model ED model ED model ED model 
2000 ED model ED model ED model ED model ED model 
5000 6_G1R1A1U3_u4 6_G1R1A1U3_u4 ED model ED model 7_G1R2A1U3_r1 
10000 6_G1R1A1U3_u4 6_G1R1A1U3_u4 ED model 7_G1R2A1U3_r1 7_G1R2A1U3_r1 
15000 6_G1R1A1U3_u4 6_G1R1A1U3_u4 6_G1R1A1U3_u4 7_G1R2A1U3_r1 7_G1R2A1U3_r1 
25000 6_G1R1A1U3_u4 6_G1R1A1U3_u4 6_G1R1A1U3_u4 7_G1R2A1U3_r1 7_G1R2A1U3_r1 
Dataset: LC-MS (split); Objective function: log difference; Selection criterion: AICc; Optimization method: SAGA-optimize. 





Figure 5.9. Comparison of the log of optimization steps where model selection with 
different datasets begins to fail with absolute difference of logs objective function.  
 
5.4 Discussion 
Here, we discussed the importance of model selection in isotopic flux analysis as a 
proxy for metabolic flux analysis and factors that affect robust model selection. We found 
that it is not the optimization method per se, but the degree of optimization that influences 
model selection, due to the effects of over-optimization, i.e. fitting of model parameters 
based on the error in the data. Overfitting is a known problem typically due to the ill-
conditioning of the nonlinear inverse problem that is partially ill-posed. Moreover, the 
objective function in model optimization is also of great importance in model selection. 
Proper selection of an objective function can help increase resistance to failure in model 
selection. This may mean that different objective functions should be used for model 
selection versus parameter optimization for flux interpretation. Most SIRM experimental 
datasets have few collected replicates and time points due to the cost and effort required to 
acquire these datasets. The lack of replicates makes it impractical to directly estimate error 
in many of these datasets. Also, the presence of different types of systematic error like ion 
suppression can limit the overall effectiveness of replicate-based error analysis. With our 
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moiety modeling framework, we are able to conduct a set of gradient experiments with 
varying amounts of optimization (i.e, number of optimization steps) using the SAGA-
optimize method to estimate the failure point in model selection caused by overfitting. 
Furthermore, we found that incorporation of less informative datasets can hinder successful 
model selection since they cannot properly represent the incorporation of isotopes 
simulated by moiety models, which can lead to increased errors in model selection. On the 
other hand, combination of informative datasets (i.e. time points with significant isotope 
incorporation) can help control failure in model selection, which suggests that informative 
datasets in public metabolomics repositories can be combined to facilitate robust model 
selection. Moreover, these datasets do not need to come from identical biological systems, 
just biological systems that utilize the same part of metabolism being measured and 
modeled. The implication is that SIRM datasets in public repositories of reasonable quality 
can be combined with newly acquired datasets to improve model selection. Furthermore, 
curation efforts of public metabolomics repositories to maintain high data quality and 
provide metrics of measurement error could have a huge impact on future metabolic 




CHAPTER 6. CONCLUSION 
In this project, we worked on the development of computational methods and tools for 
analyzing and interpreting metabolomics data derived from SIRM experiments. Despite 
SIRM experiments which can generate enriched metabolic features containing isotopic 
flow through cellular metabolism, the lack of corresponding analytic tools and methods 
greatly hinders the characterization of metabolic phenotypes and their downstream 
applications. Both detailed metabolic modeling and quantitative analysis methods are 
required for better interpretation of the complex metabolomics data. Currently, there is no 
relatively comprehensive metabolic network at an atom-resolved level that can be used for 
deriving context-specific metabolic models for a given metabolic profile. In addition, most 
existing software packages conduct metabolic flux analysis based on a predefined 
metabolic model, where novel metabolic mechanism can hardly be detected. Besides, a 
well-defined metabolic model is hard to achieve for complex biological system given the 
limitations in our knowledge. Here, we developed a set of methods and tools to help address 
those problems. 
In Chapter 2, we developed a graph coloring method that creates unique identifiers for 
unique atom as well as same identifier for symmetric atoms in a compound. Therefore, 
additional cross-reaction atom mappings caused by symmetric atoms can be captured, 
contributing to the construction of a more complete atom-resolved metabolic network. In 
addition, the ordered compound coloring identifiers derived from the corresponding atom 
coloring identifiers facilitate compound harmonization across metabolic databases, which 
is an essential first step in cross-database network integration. While harmonizing 
compounds between KEGG and MetaCyc, the graph coloring method also detected various 
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issues and errors in both databases, suggesting that this method can also be used for 
curating current metabolic databases. More importantly, the graph coloring method and 
compound harmonization approach can be used to integrate any metabolic database that 
provides a molfile representation of compounds, which will greatly facilitate future 
expansion. 
In addition to harmonizing compounds with specified atomic compositions, we 
further integrated compounds with R group(s) via an optimized common subgraph 
isomorphism algorithm in Chapter 3. We also addressed the issue of inconsistent atomistic 
characteristics across databases by defining a set of relationships between compounds. 
Meanwhile, the hierarchical relationships between metabolic reactions were created in 
accordance with the classification of compound pairs. This hierarchical framework for 
relating compounds and reactions can be an essential step to creating a comprehensive 
organization of all reaction descriptions at a desired chemical specificity to fit a given 
application.  Such a comprehensive organization of reaction descriptions would be useful 
to a wide range of possible applications, including metabolic modeling, metabolite and 
reaction prediction, and network incorporation of newly discovered metabolites.  
In addition, we made use of the atom identifiers derived from the neighborhood-
specific graph coloring method to evaluate the consistency of atom mappings across 
harmonized reactions. Through the evaluation, we figured out that the documentation of 
atom mappings in either database can contain issues. Compared to other representations, 
KEGG RCLASS provides a concise RDM description of reaction atom mappings between 
a reaction-product compound pair, which appears more resistant to consistency errors. This 
resistance to consistency error is due to a separation of the atom mappings from the specific 
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atom order in the molfile representations, which allows update molfile representations 
without affecting the RDM descriptions. However, a few KEGG RCLASS entries are 
computationally hard to parse due to a combinatorial issue caused by the several factors: 
multiple reaction centers in a single reaction, symmetric compounds, and reaction 
descriptions involving multi-steps. This combination of factors introduces a large number 
of possibilities when match reaction center atoms to the RDM descriptions. To prevent this 
combinatorial problem, one possible solution is to represent multiple reaction center atoms 
with their match atoms and associated difference atoms within a paired substructure 
representation, like sdfile.  
The above work helps to build a comprehensive atom-resolved metabolic network. 
However, this is just the first step in interpreting metabolomics datasets. In Chapter 4, we 
presented a moiety modeling framework for deconvoluting metabolite isotopologue 
profiles using moiety models along with the analysis and selection of the best moiety 
model(s) based on the experimental data. This moiety modeling framework successfully 
integrates model representation, model optimization, and model selection together. To our 
knowledge, this is the first framework that can analyze datasets involving single and 
multiple isotope tracers as demonstrated on simulated datasets for multiple tracer models 
and both simulated and experimental datasets on single tracer models. Furthermore, rather 
than a single predefined metabolic model, this method allows comparison of multiple 
metabolic models derived from a given metabolic profile. In addition, we demonstrated the 
robust performance of the moiety modeling framework in model selection on real 
experimental datasets with a 13C-labeled UDP-GlcNAc isotopologue dataset. The selection 
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of correct moiety models is the premise for generating deconvolution results that can be 
accurately interpreted in terms of relative metabolic flux.  
In Chapter 5, we further explored the data quality requirements and the factors that 
affect model selection. We have demonstrated the importance of model selection in 
isotopic flux analysis as a proxy for metabolic flux analysis. Here, we found that it is not 
the optimization method per se, but the degree of optimization that influences model 
selection, due to the effects of overfitting. Moreover, the objective function in model 
optimization also plays important role in model selection. Our results indicated that proper 
selection of an objective function can help increase resistance to failure in model selection, 
which suggests that different objective functions should be used for model selection versus 
parameter optimization for flux interpretation. It is often difficult to acquire SIRM 
experimental datasets with enough replicates at multiple time points due to the cost and 
effort, making it impractical to directly estimate error in these datasets. In addition, 
different types of systematic error can limit the effective replicate-based error analysis. To 
address this problem, we can conduct a set of gradient experiments with varying 
optimization degree using the SAGA-optimize method to estimate the failure point in 
model selection caused by overfitting. We also found that incorporation of less informative 
datasets can hinder successful model selection since they lack enough information 
representing the incorporation of isotopes simulated by moiety models, leading to 
increased errors in model selection. On the other hand, combination of informative datasets 
can help control failure in model selection, suggesting that informative datasets in public 
metabolomics repositories can be combined to facilitate robust model selection. More 
importantly, these datasets do not need to come from the same biological systems. We just 
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need to make sure that the biological systems utilize the same part of metabolism being 
measured and modeled. The implies that SIRM datasets in public repositories of reasonable 
quality can be combined with newly acquired datasets to improve model selection. 
Therefore, curation efforts of public metabolomics repositories to maintain high-quality 
data and provide metrics of measurement error could have a huge impact on future 
metabolic modeling.   
In conclusion, compound and reaction harmonization through the neighborhood-
specific coloring method can help build a more comprehensive metabolic network, which 
will help derive the proper context-specific metabolic models for metabolic flux analysis. 
The moiety model modeling framework has demonstrated its robust performance in 
isotopologue deconvolution and moiety model selection. We also devised a strategy to deal 



















APPENDIX 1.  SOFTWARE 
moiety_modeling software:  
GitHub - https://github.com/MoseleyBioinformaticsLab/moiety_modeling 
PyPI - https://pypi.org/project/moiety-modeling/ 
SAGA-optimization package:  
GitHub - https://github.com/MoseleyBioinformaticsLab/SAGA_optimize 




















APPENDIX 2.  DATA AVAILABILITY 
Atom Identifiers Generated by a Neighborhood-Specific Graph Coloring Method Enable 
Compound Harmonization across Metabolic Databases: 
https://doi.org/10.6084/m9.figshare.12894008. 
Hierarchical Harmonization of Atom-Resolved Metabolic Reactions across Metabolic 
Databases: https://doi.org/10.6084/m9.figshare.14703999. 
Moiety Modeling Framework for Deriving Moiety Abundances from Mass Spectrometry 
Measured Isotopologues: 
https://figshare.com/articles/moiety_modeling_framework/7886135. 
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